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Abstract 
Platelets are critical cells in hemostasis and thrombosis, but they are also 
involved in many important physiological events including inflammation, host 
defense, wound healing and malignancy. Platelets pursue their physiological 
functions mainly as secretory cells. The three distinct platelets granules, α- and 
δ- granules and lysosomes, serve as storage units for critical biological 
mediators. Upon action of a stimulus, platelets release their granules through a 
conserved mechanism called exocytosis. Because blood platelets are quite small 
(2-3 µm in diameter) and activate easily, until the recent work in the Haynes 
group, measurements were limited largely to morphological studies 
(electron/light/fluorescence microscopy) and ensemble aggregation and release 
assays, missing fundamental dynamics about chemical messenger delivery. The 
measurements of platelet δ-granule secretion by using carbon fiber 
microelectrode amperometry (CFMA) enabled real-time monitoring secretion of 
serotonin from platelet δ-granules with sub-ms time resolution. The aim of this 
thesis is to exploit these single cell measurements to study the fundamentals of 
platelet secretion behavior and advance our current understanding of platelet 
exocytosis.  
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A brief introduction to the platelet biology and single cell platelet measurements 
are given in Chapter 1. Since the major step involved in platelet granular 
secretion is fusion of the granules to either the membrane tubular system known 
as the open canalicular system (OCS) or the plasma membrane, Chapter 2 
investigates the difference in the secretory behavior of the platelets of different 
species that has OCS or does not have an OCS. CFMA measurements 
performed on mouse, rabbit and cow platelets indicate that OCS is necessary for 
an efficient secretory function.  
Fusion of the granular membrane with the plasma membrane is mediated by 
both membrane protein and lipid components. While membrane proteins anchor 
granular membrane with plasma membrane and facilitate fusion, membrane 
lipids not only regulate the membrane fluidity and curvature they also mediate 
localization of the fusion proteins on the site of the fusion. Although dynamin-
related protein1 (Drp1) is best known as a mediator of membrane fission, recent 
work showed that it also contributes to granule exocytosis by mediating fusion 
pore expansion in chromaffin cells. However, there was not any information on 
the role of Drp1 on platelet granule secretion. To assess whether Drp1 functions 
in platelet exocytosis, we tested the effect of mdivi-1, a Drp1 inhibitor, on the 
release of dense granules by using single-cell amperometry (Chapter 3). The 
results demonstrate the role of Drp-1 in fusion pore dynamics, and indicate that 
regulation of platelet fusion pore expansion can be used to control thrombus 
formation in vivo. 
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Phospholipids are the major components of the plasma and granule membrane, 
and in addition to their structural importance as a cellular barrier that separates 
the intracellular and extracellular environment, they are also dynamically involved 
in and regulate many cellular processes. However, there is not much known 
about how the different phospholipids regulate platelet behavior. Chapter 4 
examines the effect of membrane phospholipids on the major platelet functions of 
aggregation and exocytosis and demonstrates that different phospholipids can 
act on different aspects of platelet function. 
Besides their physiological importance, platelets can serve as an ideal model 
system for studying exocytosis. In the last part of the thesis, we compare the 
effect of cholesterol on chromaffin cells, a well-studied model cell for neural 
secretion, and platelets. Chromaffin cell exocytosis at altered cellular cholesterol 
levels was measured at single cell level and results were compared to the 
previously published work by Ge et al on cholesterol effects on platelet secretion. 
This work demonstrated that the effect of cholesterol on each cell type was 
different which is likely due to the fact that, unlike platelets, chromaffin cells have 
a nucleus and a significant synthesis capacity that enables them to tightly 
regulate various cell functions. 
Overall, the experiments performed herein expand our current understanding of 
the mechanism of platelet secretion and demonstrate that studying platelet 
vi 
 
secretion at the molecular level is essential to control platelet function for 
therapeutic purposes.  
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1.1. General Overview 
Platelets were first described by Osler in the 1870s as “organisms” found in the 
blood that cause blood to coagulate, and it was not until the early 1900s that they 
were identified as anuclear cells derived from megakaryocytes in bone marrow.1 
Since then, there has been a massive amount of research performed to 
understand and demonstrate the function of platelets in many important 
physiological events. Even though platelets are best known for their role in 
hemostasis and thrombosis, researchers are now well aware of platelet 
involvement in inflammation, atherosclerosis, angiogenesis, wound healing, and 
host defense. Platelets are quite small, with a diameter of 2-5 m. The average 
lifespan of a platelet in the blood stream is 7-10 days unless they get activated 
due to a vascular injury.1 After circulating for 7-10 days, they are taken up by the 
reticuloendothelial system. Although they lack nuclei, platelets are highly 
specialized cells with three different granule types and a special membrane 
tubular unit known as the open canalicular system (OCS) in addition to the all 
other organelles that are common in other cell types.2 There are more than 80 
granules present in a single human platelet. α- granules are the most abundant 
platelet granule type, serving as a storage unit for biologically important proteins, 
including growth factors, adhesion proteins, and various chemokines. δ-granules 
contain relatively lower molecular weight ionic and molecular species including 
Ca2+, Mg2+, ATP, polyphosphate, and the important neurochemical serotonin. 
The last class of granules found in platelets is lysosomes for endosomal 
3 
 
digestion.1, 3-5 Platelets are dynamic secretory cells, and they communicate with 
other cells during important biological processes by secreting granule-stored 
chemical messengers through a conserved mechanism called exocytosis.4, 5 
Platelet secretion is a crucial step in all the important physiological processes 
involving platelets. Unfortunately, the actual mechanism of platelet granular 
storage and secretion is not well understood. Although bulk secretion assays are 
useful to monitor platelet secretion for diagnostic purposes or to evaluate 
average platelet behavior in certain physiological conditions, they cannot give 
any mechanistic information about the secretion event. The small size of platelets 
and the unique membrane features make them difficult to study with 
electrophysiological techniques. Recently, the Haynes group pioneered 
measurement of platelet δ-granule secretion at the single cell level by using 
carbon-fiber microelectrodes and enabled the detailed analysis of platelet 
secretion from each individual granule with sub-ms time resolution.6-8  This 
opened the possibility of studying the effect of membrane proteins and lipids that 
are involved in platelet exocytosis and filling important gaps in our current 
understanding of platelet secretion. 
 
1.2. Platelet Granules  
TEM images of platelets show the presence of three different granular structures 
in a single platelet. α-granules constitute the largest granule population in 
platelets and can be identified in transmission electron micrograph (TEM) images 
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based on their round shape and uniform dark color (Figure 1.1). 9  
Immunofluorescence can also be used to monitor -granules by labeling certain 
resident proteins. However, recent evidence showed that heterogeneity of the 
constituents of the α-granules may not allow visualization of all the α-granules 
present in platelets by immunofluorescence. 10, 11 
α- granule formation initiates in megakaryocytes whereas development and 
maturation continues both in megakaryocytes and formed platelets. Formation of 
the α-granules within megakaryocytes occurs via two different mechanisms: 
endogenous synthesis and endocytosis. In the synthetic pathway, the proteins 
synthesized in the endoplasmic reticulum (ER) are transferred through trans-
Golgi where the multivesicular bodies are formed and bud off. Alternatively, α-
granules can be formed via endocytosis of plasma-bound proteins and targeted 
as α-granules by the clathrin-coated vesicle pathway. 9, 12 Although most of the α-
granule proteins are synthesized in megakaryocytes, including platelet factor 4 
(PF4), some of the proteins are taken up by receptor-mediated endocytosis, 
including fibrinogen and albumin.13  α-granules store more than 300 biologically 
active proteins including adhesion molecules, chemokines, procoagulant 
molecules, growth factors, angiogenic modulators, and fibrinolytic regulators 
(Table 1.1).1 Storage of high protein content requires intragranular maintenance 
of the osmolarity at a level similar to that of the cytosol; this may be achieved via 
aggregation of the proteins during protein sorting.9, 12 Normal human platelets 
contain about 5-7 dense granules (δ-granules) per platelet although the number 
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of delta granules can be as high as 20 in other species such as rabbit platelets. 
δ-granules can be identified in TEM images by their bulls eye-like shape, with a 
dense core and halo region.1, 14 Initial studies regarding delta granule formation 
suggested that δ- granules did not propagate from the Golgi network; in fact, they 
originate from endosomal compartments. Furthermore, recent confocal imaging 
studies have demonstrated the formation and maturation of the δ- granules from 
both early and late endosomes, regulated by AP-3, Rab32, and Rab38 proteins. 
4, 15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 TEM image of a platelet. Apparent structural features; δ- and α-
granules and OCS are shown with arrows. 
 
α-granule 
δ-granule 
OCS 
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The content of δ-granules include ATP, Ca2+, Mg2+, polyphosphate and 
serotonin, among others, which are up taken by receptor-mediated endocytosis 
(See table 1.1 for the full list). 1, 6 The pH of the δ- granules is kept around 5.4 by 
proton pumps that reside on the granular membrane. High concentrations of Ca2+ 
and polyphosphate can be stored in these granules through ionic interactions 
without disturbing the osmolarity of the granule.  
Lysosomes are ubiquitous granules in all cell types. In platelets, lysosomes 
contain a variety of enzymes, including β-N-acetyl-D-hexosaminidase, proline 
carboxypeptidase, and cathepsins.  Although there have not been many studies 
performed on lysosomal function in platelets, they may act as endosomal 
digestion unit as they do in nucleated cells. 1, 16  
 
1.3. Platelet Granular Release  
Platelets are dynamic secretory cells and, similar to neurons and chromaffin 
cells, platelets secrete their granular content via exocytosis.4, 5, 17 Upon 
activation, intracellular Ca2+ concentration increases which leads to docking of 
the granules and fusion of granular and plasma membrane facilitated by a class 
of anchoring proteins called SNARE (soluble N-ethylmaleimide-sensitive factor 
attachment protein receptor) proteins (Figure 1.2). Some of the soluble granular 
contents start to diffuse from granules into the extracellular matrix. As the fusion 
pore loses its stability and starts to expand, the exchange between granular 
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content and extracellular matrix acts as a driving force to further extrude granular 
content. 
 
 
Table 1.1 A partial list of platelet granule content 1 
α-Granule Adhesion molecules P-Selectin, von Willebrand factor, fibrinogen, 
fibronectin, integrin αIIbβ3,  
  
Chemokines 
 
Platelet factor 4, β-thromboglobulin, CCL3, 
CCL5 (RANTES), CXCL5, CXCL8 
  
Coagulation pathway 
 
Factor V, multimerin, factor VII 
  
Fibrinolytic  pathway 
 
α2-Macroglobulin, plasminogen, 
plasminogen activator inhibitor 1 
 Growth and angiogenesis Basic fibroblast growth factor, epidermal 
growth factor, hepatocyte growth factor, 
vascular endothelial growth factor C, platelet 
growth factor 
  
Immunologic molecules 
 
β1H Globulin, factor D, c1 inhibitor, IgG 
  
Other proteins 
 
Albumin, α1- antitrypsin, Gas6, histidine rich 
glycoprotein, high molecular weight 
kininogen, osteonectin protease nexin-II 
 
δ- Granule 
 
Ions 
 
Ca, Mg, P, pyrophosphate 
  
Nucleotides 
 
ATP, GTP, ADP, GDP 
  
Membrane proteins 
 
CD63 (granulophysin), LAMP2 
  
Transmitters 
 
Serotonin 
Lysosomes   Cathepsin D and E, β-N-acetyl-D-
hexosaminidase, proline carboxypeptidase 
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However, as has been recently shown by Ewing and coworkers, even at the 
stage commonly known as “full fusion” in which the complete fusion of granular 
and plasma membrane takes place, not all the content of the granules is 
secreted. 18 In fact, PC12 cells, a model primary cell line for neural secretion, 
only release 40% of their content. Although such analysis has not been done for 
platelet granular release, comparison of the released serotonin to total serotonin 
content with bulk HPLC measurements suggests that platelets also release only 
a portion of their granular content. Moreover, initially formed fusion pores may 
pinch closed, allowing only limited chemical messenger release known as kiss-
and- run exocytosis. 7, 19 Unlike other secretory cells, platelets can also secrete 
their content by fusion of the granules to the OCS.20 This brings up the question 
of if the platelets are “smart” secretory cells and how their granular secretion is 
regulated. Although the mechanism of platelet granular secretion is not well 
understood, it is clear that there are multiple levels that control the extent of 
secretion.21 One of the key steps involved in exocytosis is the fusion of the 
granular membrane with the plasma membrane. Recent evidence in the literature 
shows that fusion pore stability regulates not only the mechanism but also the 
quantity of molecules secreted.22-25 Moreover, fusion pore diameter can act as a 
physical barrier, allowing only the molecules below a certain size to move into the 
extracellular space. Although the actual structure of the fusion pore is under 
debate, it is clear that both protein and lipid membrane components play an 
active role in the formation and regulation of the membrane fusion site.  
9 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Steps of exocytosis. 21 
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1.3.1 Membrane Proteins 
Although the granular and plasma membranes in platelets, both critically 
important in secretion, are mostly composed of lipids, membrane proteins play a 
central role in facilitating the membrane mixing process. Similar to many 
secretory cells, platelets use SNARE machinery for membrane fusion. The 
SNARE proteins that reside on the granular membrane are called vesicle 
associated membrane proteins (VAMPs) or synaptobrevins.VAMP2, 3, 7 and 8 
constitute the VAMP proteins of platelet secretory machinery.26-28  The relative 
importance of the various VAMP proteins during platelet exocytosis has been 
studied using a variety of genetic knockout mice. Deletion of the VAMP2 and 
VAMP3 gene did not cause any secretion defect in platelets. However, defects in 
secretion and aggregation were observed with VAMP8-/- (VAMP 8 double 
knockout) platelets with low concentration thrombin stimulation. 27, 29, 30 The 
platelet secretion defect in the VAMP8 knockout platelets was rescued when 
higher concentration thrombin stimulation was applied, implying that other VAMP 
proteins compensate for the lack of VAMP8 at high agonist concentrations. 
Moreover, impaired VAMP8-/- platelet secretion resulted in compromised 
thrombus formation in mice with laser-induced injury. 26, 27  VAMP7 is unique as it 
is the only VAMP with a N-terminal profilin-like domain. Recent work from 
Flaumenhaft group demonstrated that VAMP7 is mainly found on α-granule 
surfaces and it plays a central role in granule relocalization during platelet 
spreading. Granules expressing normal VAMP3 and VAMP8 move toward the 
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center of the platelet following activation; however, VAMP7-expressing granules 
reside at the platelet periphery.28 
 The cell membrane-associated SNARE proteins (also known as t-SNAREs) 
found in platelets are syntaxin-2, -4, -7, -11 and SNAP23, 25 and 29.4, 31-33  
Currently, there is no known effect of syntaxin-7 on platelet granule release; 
however, antibody-based work focused on syntaxin-2 and syntaxin-4 showed 
that syntaxin-2 was required for release of all granule types in platelets and 
syntaxin-4 was crucial for release of α-granules and lysosomes. Due to the 
inconsistencies in the results from different groups, the Whiteheart group 
(Haynes group collaborator who prepares SNARE knockout mice) recently 
revisited the role of syntaxin-2 and -4. They saw normal release behavior from 
syntaxin-2-/-, syntaxin-4-/- and syntaxin-2,-4 double knockout mouse platelets, 
arguing that, in fact, none of these syntaxin isoforms are required for normal 
platelet exocytosis.32, 34, 35  
In addition to SNAREs, platelets also have Ca2+-binding proteins that are shown 
to regulate exocytosis. In neurons and chromaffin cells, Ca2+-binding proteins 
have been identified that regulate SNARE assembly and fusion pore formation. 
Synaptotagmins are major regulators of the fusion pore feature both based on 
interaction with t-SNAREs and also with phosphatidylserine (PS), which is known 
to regulate membrane curvature.36, 37 Synaptotagmin-like proteins (Slp) 1 and 4 
are found in platelets. Neumueller et. al. showed that Slp1 binds to Rap1GAP2 in 
platelets although Slp1 appears to have the opposite effect on platelet δ-granule 
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release as that seen in chromaffin cells.38  Addition of Slp1 to permeabilized 
platelets inhibits δ-granule release in a dose-dependent manner whereas 
Rap1GAP2 addition facilitates δ-granule release. Addition of Slp1 and 
Rap1GAP1 together does not change the inhibitory effect of Slp1 on platelet -
granule release, implying that although Slp1 binds to RapGAP1 in platelets, this 
interaction does not play a role inhibiting Slp1. Munc 18 is another SNARE 
regulatory protein, and it was shown that the inhibition of Munc 18 action 
attenuates secretion as well.39 
Although the studies on platelet protein secretory machinery has provided the 
basis of the regulation of platelet secretion knowledge, a more detailed analysis 
is required even for the proteins that has not shown any effect on platelet 
secretion.  It is possible that those proteins may control the kinetics of the release 
but not the quantity, a characteristic that cannot be detected with traditional bulk 
assays.  
 
1.3.2 Membrane Lipids 
Phospholipids constitute the major lipids of the cell membrane, and they are 
asymmetrically distributed. In resting conditions, phosphatidylethanolamine (PE) 
and phosphatidylserine (PS) reside largely on the inner leaflet of the plasma 
membrane whereas the outer leaflet is dominated by cholinephospholipids, 
including phosphatidylcholine (PC) and sphingomyelin (SM).40, 41 Exocytosis, a 
process that relies on asymmetric distribution of phospholipids, causes 
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redistribution of these phospholipids between the inner and outer leaflets; the 
arrangement of phospholipid species in the inner and outer leaflet has been 
shown to regulate both quantity and kinetics of release from PC12 cells (a model 
exocytotic system).41 Phospholipids in the membrane regulate fusion pore 
formation both by changing the curvature of the membrane and by 
accommodating the proteins that are essential for fusion pore formation. For 
example, the PS - synaptotagmin interaction is known to regulate fusion pore 
stability in PC12 cells in a calcium-dependent manner.40 In platelets, the 
maintenance of this asymmetric phospholipid distribution has critical 
physiological implications for hemostasis.42, 43 For example, circulating platelets 
maintain the majority of the aminophospholipids (PS and PE) on the inner 
membrane leaflet, whereas activated platelets rapidly lose their asymmetric 
phospholipid distribution and elevate otherwise low levels of PS. This change 
makes the platelet membrane surface negatively charged and presents more 
catalytically active lipid membrane surface for hemostatic purposes.43, 44 The 
dynamic platelet activation-induced phospholipid redistribution occurs during 
platelet secretion but secretion has not been monitored with controlled or 
characterized phospholipid composition.  
In addition to phospholipids, cholesterol is a ubiquitous sterol molecule, highly 
enriched in all mammalian cell membranes and abundant in the platelet 
membrane.23, 45-47 Structurally, cholesterol is a short and rigid molecule known to 
modulate membrane physical properties, including fluidity and elasticity, by 
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intercalating into the long and flexible phospholipid bilayer. In addition to its 
structural role in the lipid membrane, cholesterol is widely known to play versatile 
roles in various membrane-based cellular processes. For platelets, cholesterol is 
clearly a molecule of physiologic importance and known to regulate various 
aspects of platelet functions in the blood stream, including the tendency for 
aggregation.45 In fact, previous studies have clearly shown that the abundance of 
platelet cholesterol is closely tied to the reactivity of circulating platelets in the 
blood stream. Hypercholesterolemia is often considered a high risk factor for 
various diseases, including stroke and heart attack. It is widely recognized that 
platelet cholesterol plays critical roles in various normal and dysfunctional 
platelets. Several recent studies on non-platelet secretory cells have clearly 
indicated that membrane cholesterol plays a vital role in the delivery of various 
chemical messengers, such as insulin from β-cells and neurotransmitters from 
neurons.48, 49 Mechanistic investigations have shown that cholesterol not only 
spatially organizes the exocytotic SNARE complex in the lipid membrane, likely 
by forming cholesterol-enriched microdomains or lipid rafts, but also actively 
regulates the membrane fusion process during granule secretion on the basis of 
its physical character.  
1.4. Importance of Platelet Granular Secretion in Physiological Events 
Undoubtedly, platelet secretory function is critical for not only hemostasis but it is 
involved in many physiological events including thrombosis, inflammation and 
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malignancy. Herein, the contribution of platelet secretion to each of these events 
is summarized.  
One major function of platelets is to stop bleeding upon vascular injury.   The 
pathology of the hemostatic function of platelets is called thrombosis, wherein 
overactive platelets cause inappropriate clot formation that can lead to stroke and 
heart attack. Bleeding disorders encountered with α- and δ- granule release 
deficiencies (α-granule deficiency is called gray platelet syndrome; Hermansky- 
Pudlak syndrome and Chediak Higashi syndrome are associated with the 
absence of δ-granules) prove that the secretory function of platelets is crucial for 
hemostasis.50  Upon a vascular injury, subendothelial extracellular matrix, which 
contains VWF, laminin, thrombospondin, and fibronectin, is exposed and binds 
platelet receptors to promote platelet adhesion and secretion.50 Although the role 
of platelet α-granules in hemostasis is not clear, the stored VWF and fibrinogen 
not only enhance the adherence of the platelets with each other but also enables 
the recruitment of more platelets to the site of the injury. α- granules also store 
coagulation factors that are essential for formation of a stable clot.50 Platelet δ 
granules are the main players in hemostasis. Both serotonin and ADP are 
platelet agonists which enable the activation and recruitment of additional 
circulating platelets.3, 14, 51 Moreover, recent evidence shows that polyphosphate 
found in platelet δ-granules also acts as a procoagulant.52 
Platelets participate in both immune and inflammatory reactions by secreting 
important mediators from α- and δ- granules that target the cells of the innate and 
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adaptive immune systems.53 TNF-α produced during early stages of inflammation 
promotes fibrin and thrombin formation and activates platelets. Activated 
platelets contribute to inflammatory action by secreting proinflammatory 
cytokines and chemokines, including P-selectin, CD40L, interleukin-Iβ, RANTES, 
PF4, and β-thromboglobulin.12, 53 During atherosclerosis, a typical example of 
chronic inflammation, platelets secrete P-selectin and VWF that are involved in 
atherosclerotic lesion development.3, 53 As immune cells, platelets help monocyte 
recruitment and neutrophil adhesion and degranulation by releasing PF4 and β-
thromboglobulin. Platelet δ- granule polyphosphate has been shown to induce 
vascular leakage and edema formation in vivo.52 
Rapid tumor destabilization in the case of thrombocytopenia (low platelet count) 
evidenced that platelets are required for tumor stability.  P-selectin mediates 
direct interaction of platelets with tumors and initiates platelet-tumor aggregation. 
Tumor cells use platelets like a Trojan horse and hide from immune cells this 
way. In fact, platelet growth factor (PGF) secreted from platelet α-granules 
promotes tumor growth. Moreover, the angiogenesis factors secreted from α-
granules mediate tumor angiogenesis, growth and metastasis.12, 54 The mitogenic 
effect of serotonin secreted from platelet δ-granules has also been shown in 
variety of cancer types.55 
Involvement of platelet granule secretion in variety of physiological events makes 
the studies on platelet secretory dynamics important to reveal the fundamental 
underpinnings of disease. 
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1.5. Common Methods Used to Assess Platelet Granular Storage and 
Secretion. 
In addition to basic research interest, platelet granular secretion is routinely 
analyzed for diagnosis and for monitoring the prognosis of a disease in clinics. 
Either P-selection expression or ELISA assays are used to analyze α- granule 
release. Platelet delta granule release is commonly monitored by measurement 
of released ATP/ADP or radiolabelled serotonin. 
P-selectin secreted from platelet α-granules is expressed on the surface of the 
platelets and thus, can be labeled by using a fluorophore-conjugated P-selectin 
antibody for flow cytometry analysis.56 Although this method is useful for 
quantitative analysis, it does not provide any information about the kinetics of the 
release event. ELISA is an alternative to flow cytomety for α-granule analysis; for 
instance, there is a commercially available PF4 ELISA assay that is commonly 
used. Although both of these methods are precise and accurate, they require 
long sample preparation and incubation times and a lot of pipetting.  
Secretion of serotonin from platelet δ-granules is often monitored following 
incubation with radiolabelled serotonin, [3H]-serotonin or [14C]-serotonin, for 
about 1 hour.56 Secretion of the platelets upon activation with an agonist is 
measured via scintillation measurements. The results are recorded as percent 
release where unstimulated samples are used as basal controls.  
[(Sample-mean basal)/ (mean total-mean basal)]X100=% 5-HT release. 
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One of the drawbacks of this method is that it only measures the release of the 
radiolabelled serotonin that was taken up by platelets (rather than an 
endogenous species), and thus it does not provide information about granular 
storage. A luciferin-luciferase assay can also be used to measure ADP/ATP 
release to monitor δ- granule secretion.56, 57 Conversion of the luciferin to 
oxyluciferin is a common example of chemoluminescence and catalyzed by ATP; 
thus, this reaction is used for the detection of the ATP from platelet δ-granules. 
For the detection of ADP, pyruvate kinase/ phosphoenolpyruvate (PK/PEP) is 
added to the system which converts ADP to ATP. Any increase in the 
luminescence output upon addition of (PK/PEP) is used for the analysis of ADP. 
This assay is very sensitive and allows the measurement of ADP at picomolar 
levels.  
β-hexosaminadase is a lysosomal enzyme that catalyzes the hydrolysis of N-
acetylglucoseamines and N-acetylgalactoseamines. To detect the lysosomal 
release from platelets, nitro-phenyl derivatives of N-acetylglucoseamines and N-
acetylgalactoseamines are used as a substrate for the β-hexosaminadase-
catalyzed formation of nitrophenol.58  
 
1.6 Single Cell Study of Platelet δ- Granule Secretion 
Ensemble measurements of platelet secretion provide useful insights about 
platelet secretion behavior under certain conditions. The main weakness of bulk 
measurements is that they average the parameters, making it impossible to 
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characterize heterogeneity in cellular function.  Moreover, the molecular 
dynamics of cell function is often not accessible with these techniques.59, 60 
Ensemble measurements of cellular function are often performed with the cell 
densities ranging from 103-107cells/mL and may require large sample volumes. 
Assessment of the cellular function at the single cell level is gaining popularity 
due to the advantages it provides over ensemble cellular assays. The main 
advantage of single cell analysis is that it enables the identification of the 
distribution of cell behaviors and identification of outliers that reflect the diversity 
of cellular function.59, 61 Since measurement from a single cell type in a mixture of 
cells is possible, tedious sample preparation and purification procedures are not 
required. Single cell analysis often enables real time analysis of the cellular 
function and provides mechanistic insights. Due to their small size, single platelet 
measurements are challenging. However, recent advances in single cell 
microelectrochemical analysis of platelet serotonin release from δ- granules 
made measurement of platelet secretion at the single granule level, with sub-ms 
time resolution, possible.  
 
1.7 Carbon Fiber Microelectrochemistry  
The use of carbon as an electrode material was first popularized by Ralph 
Adams in the 1950s. 62 Since its inception, carbon has been a popular choice for 
electrochemical applications, as carbon electrodes demonstrate a wide working 
potential window, stable background currents, low noise, and high sensitivity. 
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The development of carbon electrodes with active surfaces on the scale of 
several micrometers introduces several additional advantages. For voltammetry 
experiments, microelectrodes offer the ability to observe diffusion-limited currents 
at high scan rates and thus provide very fast time resolution. The small surface 
area of microelectrodes enables the use of high scan rates with relatively low 
background currents. Because of the small number of molecules that must be 
detected at the single cell level, however, most electrochemical measurements 
made with carbon microelectrodes produce currents in the nanoampere or 
picoampere range, depending on the method used. These current levels require 
electrodes that are both sensitive and exhibit low levels of noise, and carbon 
microelectrodes meet both of these criteria. Conveniently, using microelectrodes 
requires only a two electrode system, as such low currents render the use of an 
auxiliary electrode unnecessary. Perhaps most importantly, microelectrodes 
provide much greater spatial resolution, and thus permit electrochemical 
measurements to be made from single cells.63 Although other forms of carbon 
can also be used to fabricate microelectrodes, carbon fiber microelectrodes 
(CFM) are often favored because they can be fabricated in large quantities and 
are relatively inexpensive. R. Mark Wightman and co-workers first demonstrated 
the utility of carbon fiber microelectrodes for the detection of exocytosis from 
single cells in 1990.64 Carbon-fiber microelectrodes of different geometries are 
used depending on the intended application; for single cell electrochemical 
techniques, beveled and polished disk microelectrodes are most widely used. 
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While Wightman’s initial demonstration explored exocytosis from chromaffin 
cells, the cells responsible for the release of electroactive adrenaline, exocytosis 
is highly conserved across several cell types including neurons, chromaffin cells, 
platelets, and a variety of immune cells such as mast cells and macrophages. 
Accordingly, the technique has the capacity to reveal critical mechanistic details 
about exocytosis in these cell types, providing new insight into the fundamental 
behavior of normal and dysfunctional secretory cells. 
Electrochemical methods using carbon-fiber microelectrodes (CFMs) are the 
gold-standard for studying single cell exocytosis. Carbon-fiber microelectrode 
amperometry (CFMA) and fast scan cyclic voltammetry (FSCV) are the most 
widely used methods, as they allow the direct measurement of secreted 
molecules without damaging cells or interfering with endocytosis, which is a 
common issue in capacitance-based measurement methods such as patch-
clamp techniques.65 In FSCV, individual voltammograms are obtained by 
repeated application of triangular waveform scans through a range of potentials 
at regular intervals.18, 66-72 Any electroactive species that can be oxidized/reduced 
in the potential window are monitored “simultaneously”. Each scan starts with the 
electrode placed on a single cell and held at a resting potential to relax the 
diffusive layer at the electrode tip. Potential sweep in a positive direction results 
in an oxidative peak in the trace. The potential then comes back in the negative 
direction, and if the species has a reversible redox process, it results in a 
reduction peak in the voltammogram. The amplitude of the current signal 
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depends on the number of analyte molecules diffusing to the electrode surface.66 
As the scan rate is hundreds of volts per second, a large background current 
occurs during the measurement.69, 72 This background current is relatively stable 
for CFMs and can be subtracted from later scans.69 In single cell exocytosis 
studies, time-resolved chemical changes in the local environment of the 
electrode tip are obtained for each scan as the cell of interest is stimulated. 
Voltammograms obtained before stimulation of the cell are subtracted from 
voltammograms containing information related to the local chemical change after 
stimulation. This method provides chemical identification of oxidized/reduced 
species and also can be used to monitor multiple electroactive species 
simultaneously based on their oxidation potentials.70, 71 Accordingly, FSCV is 
most commonly used to identify molecules secreted from a cell. The temporal 
resolution of single cell FSCV measurements can reach the 100 ms level,72, 73 
limiting insight into the real-time kinetics of exocytosis; as a result, CFMA is 
commonly employed as a complementary technique for in-depth exocytosis 
kinetics studies. In CFMA experiments, a constant potential sufficient to 
oxidize/reduce the chemical messenger of interest is supplied at the tip of 
CFM.63, 65, 74, 75 Current at the electrode tip is monitored as a function of time. 
Oxidative current from the analyte at a positive potential is monitored while 
detection of reductive current at a negative potential can be troublesome due to 
the interference from oxygen. Upon stimulation of a single cell, exocytotic 
behavior of the cell is revealed as current spikes that represent vesicles/granules 
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of chemical messenger molecules stored in a quantal fashion, meaning that the 
concentration in each granule is approximately the same.76, 77 Each spike may 
represent one granule but it is also possible, though statistically improbable, to 
simultaneously detect multiple granules. As electron transfer is faster than 
diffusion of chemical messengers to the electrode surface, redox reactions 
occurring at the electrode are limited by diffusion of chemical messengers.63, 76 
This allows the CFMA method to achieve sub-millisecond temporal resolution 
and enables real-time monitoring of exocytotic events. In an amperometric trace, 
each spike has a fast rising and slower decaying phase due to the convolution 
effects of diffusion and dissociation of chemical messenger molecules.74 Analysis 
of various spike characteristics reveals several aspects of exocytosis such as 
granule release kinetics and membrane properties.63, 74 
 
1.7.1 Instrumentation (Experimental Setup) 
The experimental setups for amperometry and voltammetry techniques share 
many common features. CFMs are typically fabricated in-house, and the 
fabrication methods may vary slightly by laboratory. Generally, a single carbon 
fiber with 5-10 μm diameter is aspirated into a glass capillary, which is then 
pulled using a capillary puller that applies thermal and magnetic fields. With the 
use of a microscope, the extruded carbon fiber is cut back as desired depending 
on application. The carbon-fiber is next sealed in the capillary using epoxy resin 
for insulation and cured at high temperatures (100-150 ºC). Prior to 
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electrochemistry experiments, cured electrodes are polished at 45º (angle can 
vary depending on applications) using a micropipet polisher and stored tip-down 
in isopropyl alcohol to remove any surface contaminants. A typical instrument for 
CFMA and FSCV techniques includes a working electrode (the CFM) and a 
reference electrode (often a purchased Ag/AgCl electrode). Both the CFM and 
the reference electrode are connected to the potentiostat that controls the 
voltage between electrodes. Because currents due to the contents of single 
granules are quite small (nanoamp to picoamp level), a low-noise measuring 
device or patch-clamp amplifier is often employed between the CFM and the 
potentiostat. Usually, the cells of interest are cultured in a Petri dish and are 
placed in a culture dish warmer to maintain physiological temperature. An 
inverted microscope is used to visualize cells and the position of the CFM. For 
cell stimulation, a pulled capillary containing stimulant is connected to a 
pressure-driven flow controller and positioned near the cell of interest. 
Positioning of the carbon fiber microelectrode (adjacent to the single cell) and 
stimulating pipet is accomplished using piezoelectric micromanipulators (Figure 
1.3).  
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Figure 1.3 Instrumental setup for a CFM electrochemistry experiment. (A) CFM (right) is p 
laced on a single cell with the stimulating pipet (left) near the cell. (B) Bright field image of 
the experimental setup showing the CFM and stimulating pipet positioned on a single mast 
cell. (C) Representative color plot obtained by FSCV. (D) Representative amperometric 
trace obtained using CFMA on a mast cell.19 
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1.7.2 Sensitivity, Selectivity, and Resolution 
 With regard to sensitivity and selectivity, the chemical messengers that are most 
commonly analyzed using CFM have an adsorption affinity for the carbon 
surface.  As more adsorption of analyte onto the electrode surface occurs, 
measured current increases at the cost of temporal resolution.67, 68, 78 Adjusting 
the potential range, especially the resting potential in FSCV measurements, can 
control adsorption.67, 68, 79 Carbon electrode surface coatings have been used to 
increase selectivity and sensitivity of the measurement for specific chemical 
messengers, but these methods add another physical layer for analyte to diffuse 
through, sacrificing temporal resolution. The dimensions of the CFM can also 
significantly influence the measurement; small diameter CFMs significantly 
reduce the number of superimposed spikes in a trace but it also reduces the total 
number of events detected.80 In summary, there are the expected trade-offs 
between sensitivity, selectivity, and resolution when performing CFM 
measurements but adjusting the parameters mentioned above will facilitate 
optimal outcomes. 
1.7.3 FSCV Data Analysis 
In FSCV, properties of detected molecules, such as electron transfer rate, 
stability, and carbon adsorption affinity, contribute to the CV shape, peak 
position, and the ratio of forward and reverse peak intensities; therefore, 
confirmation of the identity of chemical messengers from single cells by FSCV is 
normally done by comparing obtained voltammograms to those of control 
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solutions.74, 76, 81 FSCV data is often represented in the format of a color plot 
where voltammograms (current versus potential) obtained as a function of time 
are stacked together with time on the x-axis, potential on the y-axis, and current 
coded in false color (Figure 1.4B). In this color plot format, identification of a 
specific chemical messenger is done by extracting individual CVs and comparing 
them to standards. Identity of a chemical messenger is then confirmed using a 
calculated correlation coefficient, and once identified, quantification is done by 
measuring the peak current and comparing the value with the values in a 
calibration curve previously prepared. As shown in Figure 1.4B, this color-plot 
representation facilitates visualization of the redox reactions occurring over the 
entire measurement period in one 2-D plot and has been widely used to interpret 
FSCV data, though not those measured from complex mixtures. Addressing the 
difficulty of complex mixture detection, the Wightman group has recently 
employed chemometric methods such as principal component analysis and 
principal component regression to identify feature variation within 
voltammograms and has successfully resolved and quantified nine components 
in a mixture.72, 82 
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Figure 1.4 (A) Correlation of spike parameters and phases of exocytosis. (B) 
Example false color plot of serotonin release from a platelet. (C) Voltammogram 
obtained from serotonin release of a single platelet (solid line) and serotonin 
standard solution (dotted line).19 
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1.7.4 Spike Determination and Analysis in CFMA 
After amperometric traces are obtained, the data analysis first requires identifying 
spikes and the corresponding baseline current. Usually, the root-mean-square 
current noise is measured before cell stimulation, and the spike detection 
threshold is set using a multiple of the measured noise.83 In the case of 
overlapping spikes or spikes with abnormal shape, spikes are visually selected. 
Upon baseline determination and spike selection, each trace is analyzed for 
basic spike parameters to characterize single cell exocytosis. The area 
underneath individual spikes (Q), full-width at half-maximum (T1/2), and frequency 
of spikes in a trace (f) are commonly used as basic spike parameters to describe 
each cell’s exocytotic behavior (Figure 1.4).   
 
Applying Faraday’s law, the number of moles of detected redox-active species 
(N) can be quantified. T1/2 yields kinetic information about the time required to 
release a granule’s chemical messenger content.74 f is a measure of the granule 
release pattern of a single cell upon stimulation, and it provides information about 
how granules are recruited to the plasma membrane during exocytosis. These 
parameters are reliably used to quantify the exocytotic processes of single cells 
under various circumstances.74, 83, 84 As maximum exocytosis of a granule 
generates a fast rising slope and slower decaying slope in a spike,74 several 
additional kinetic parameters can be extracted from each spike, including Trise, 
time spent from 10% to 90% of maximum intensity in the rising phase, and Tdecay, 
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time spent from 90%to 10% of the maximum intensity in the decaying phase.63 
Trise is especially interesting as it provides important information about the 
kinetics of the release event, such as the rate of dilation of the fusion pore to the 
full exocytosis state immediately following granule-cell membrane fusion and 
dynamics of molecules escaping the matrix that they are stored in.85, 86 The flux 
of redox-active chemical messengers before full exocytosis results in a 
characteristic prespike feature known as a prespike foot.74, 83 Prespike foot 
features, which were first investigated by Chow and co-workers, are diverse in 
magnitude, duration, and shape, yielding information about the dynamic nature of 
the fusion site. 
Analysis of prespike foot features often includes consideration of the number of 
spikes preceded by a foot event, charge within the foot portion of the feature 
(Qfoot), and duration of the foot before full exocytosis occurs (Tfoot) relative to the 
corresponding value for the full exocytosis spike since, for a given condition, the 
portion of the messengers released through the fusion pore should be similar.23, 
73 While much insight is accessible through detailed foot analysis, the analysis 
methods are not nearly as well established as those for full exocytosis 
amperometric spikes. Standard statistical procedures are used to compare the 
mean amperometric trace characteristics for different populations of single 
cells.63, 79 
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Class of Cell 
 
Cell Type 
 
Chemical Messenger  
(Detected by CFM) 
 
Molecules per 
Granule 
(zeptomoles)
†
 
 
Reference 
 
 
Neuroendocrine/Endo
crine Cells 
 
Adrenal Chromaffin 
Pancreatic β-Cell 
 
Epinephrine, 
norepinephrine 
Insulin 
 
5,000-10,000   
600   
 
63, 64 
87 
 Melanotrophs α-melanocyte stimulating 
hormone 
320  88 
     
Neurons Retinal Amacrine   Dopamine 8-170  89 
 Somatic Leech Serotonin 7.8  
13.3  
90 
90 
 Superior Cervical 
Ganglion 
Dopamine 58  91 
 Cultured Midbrain Dopamine 5
92
 92 
     
Hematopoetic Mast Cells Serotonin, Histamine* 1.24 x 10
6  **
 93 
 Platelets Serotonin 1000
  
 94 
 Dendritic Cells Serotonin 49.8 – 215.9   95 
     
Immortal Cell Lines PC-12 
MN9D 
Dopamine 
Dopamine 
190 
82 
96 
97 
     
*Histamine is co-stored and co-secreted with 5-HT, but has yet to be quantified per granule, 
due to the concomitant oxidation of serotonin at potentials sufficient to oxidize histamine. 
**Zmol serotonin in table refers to mast cells cultured alone. When co-cultured with fibroblasts, 
mast cell secretion of serotonin per granule increases to 1 x 10
7
 zmol.
93
 
†
The oxidations of epinephrine, norepinephrine, dopamine and serotonin are two electron 
processes. The oxidation reaction of histamine has yet to be conclusively deciphered. For 
insulin and α-melanocyte stimulating hormone, although several oxidizable moieties are 
present, the oxidation reactions for the two proteins in Table 1 are two electron processes. 
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1.7.5 Chemical Messengers and Cell Types 
As many cell types release electroactive chemical messengers stored within 
granules through exocytosis, FSCV and CFMA have been used to monitor these 
important biological processes. Table 1.2 provides an overview of the cell types 
and secreted chemical messenger species that have been examined with CFMA 
and FSCV on the single cell level, and more detail regarding electroactive 
chemical messengers and the cells from which they are secreted is provided 
here.  
Adrenal chromaffin cells are neuroendocrine cells located in the central layer of 
the adrenal gland and are of interest because of their role in the fight-or-flight 
response.63, 64, 98 Additionally, the similarities between chromaffin cells and 
neurons make chromaffin cells a good model for studying exocytosis.64 The first 
effort in monitoring single cell exocytosis was performed using stimulated single 
bovine chromaffin cells, confirming that epinephrine and norepinephrine are co-
stored and released during chromaffin cell exocytosis, with an oxidation to an o-
quinone at approximately +460 mV and reduction at approximately 150 mV vs 
Ag/ AgCl. However, because of the structural similarities of norepinephrine and 
epinephrine (Figure 1.5A,B), discrimination of these two compounds was only 
achieved at a very high potential (+1400 mV vs Ag/AgCl) where the oxidation of 
the secondary amine of epinephrine was observed.71 This approach revealed 
that some chromaffin cells store either epinephrine or norepinephrine while 
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others store both. Norepinephrine and epinephrine have been similarly detected 
from murine and rat adrenal medullary cells. Melanotrophs are neuroendocrine 
cells located in the pituitary gland that secrete α-melanocyte stimulating hormone 
(α-MSH).88 Kennedy and colleagues detected peptide exocytosis from rat 
melanotrophs, and used both CFMA and FSCV to probe the exocytosis of these 
cells. Their results indicated that the oxidation of α-MSH was the primary source 
of the amperometric spikes.  
As communication between neurons is achieved through exocytosis, the 
chemical signaling among neurons with a variety of origins and functions are of 
broad interest. Both dopaminergic and serotonergic neurons have been isolated 
and examined with CFMA. Zhou and Misler isolated cervical ganglia from rats, 
cultured individual dopaminergic and serotinergic neurons, and used CFMA to 
record amperometric spikes, the amplitudes of which were approximately 1% of 
the amperometric spike amplitudes of chromaffin cells.91 Sulzer and co-workers 
detected dopamine exocytosis from cultured midbrain neurons of rat pups.92, 99 
Dopamine has also been detected from retinal amacrine cells, which are 
dopaminergic neurons located in the retina, by Wightman and colleagues. 
Serotonergic leech neurons, called Retzius cells, have also been isolated and 
examined with CFM techniques.90, 100 Retzius cells are large (80 μm diameter) 
and can be cocultured with a receptor cell to form a serotonergic connection. 
Bruns and Jahn used CFMA to examine the exocytosis of both large dense core 
granules and small clear granules from isolated Retzius cells.90  
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Mast cells are a tissue-bound granulated cell found in organs as diverse as skin, 
brain, lungs, and connective tissue. These cells have a complex function in the 
immune system, providing a line of defense against parasitic organisms but also 
playing a primary role releasing mediators of allergic response. Millar and co-
workers used FSCV to detect exocytosis from single mast cells and to identify 
the substance exocytosed as serotonin.101 De Toledo et al. used amperometry as 
well as FSCV to probe mast cell exocytosis and determined the amount of 
serotonin secreted was 1.24×106 zmol/granule.102 Wightman and co-workers 
later employed FSCV and CFMA to determine that histamine and serotonin are 
co-stored in mast cell granules.103 The CVs of histamine and serotonin each 
have unique features that were used to discriminate between the two 
compounds. Histamine release has yet to be detected amperometically due to 
the concomitant oxidation of serotonin at potentials sufficient to oxidize 
histamine, but the concentration of secreted histamine has been quantified 
voltammetrically using its oxidation peak at +1250 mV vs Ag/AgCl.103  
In addition to primary culture cells, single cell detection of exocytotic events has 
been achieved from immortal cell lines as well; this is advantageous in that the 
cells are homogeneous, proliferate in culture indefinitely, and require no animal 
sacrifice. The most frequency examined cell line is the rat pheochromocytoma 
(PC12) cell line, which is derived from an adrenal medullary tumor and widely 
used as a model nerve cell for examining neurochemical processes. Unlike 
chromaffin cells, PC12 cells have dopamine levels 2-300 times higher than that 
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of norepinephrine levels.75, 104 Ewing and colleagues used electrochemical 
methods to probe the exocytosis of PC12 cells for the first time and established 
the identity of the exocytosed mediator as dopamine using FSCV.75, 104 
 
1.7.6 Fundamentals of Exocytosis Revealed 
Beyond the utility of quantitative detection of chemical messengers released from 
the granules of single cells for fundamental characterization, CFMs have been 
used to probe more general exocytotic phenomena such as chemical messenger 
storage and release mechanisms, fusion pore formation, and intragranular matrix 
swelling. Correlated single cell electron microscopy and CFMA studies have 
revealed that the concentration of chemical messengers within granules, across 
cell types, is 0.5- 1.0M, which is much higher than previously thought possible.105 
Most cell granules have two phases: a dense core and liquid halo. 
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Figure1.5. Molecular structure and cyclic voltammograms of (A) epinephrine, (B) 
norepinephrine, and (C) serotonin (upper, solid line in the voltammogram) and 
histamine (lower, dotted line in the voltammogram).19 
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Highly sulfonated biopolymers, such as negatively charged chromogranins in 
chromaffin cells and heparin and chondroitin sulfate in mast cells, constitute the 
dense core matrix. Ionic interactions between the matrix and chemical 
messengers and hydrogen bonding between the two at the acidic granular pH 
are suggested as the possible driving forces that allow the interior of the granule 
to be isosmotic with the cell cytoplasm by allowing only a minute amount of 
chemical messenger solubilized in the halo region. It has been shown that the 
rate of the release is strongly influenced by the dissociation of the chemical 
messengers from the matrix in chromaffin and mast cells.106-108 
As previously discussed, the formation of a fusion pore does not always lead to 
full exocytosis; in some cases, the fusion pore recloses in a process known as 
“kiss-and-run” exocytosis. This “kiss-and-run” process may be a method for cells 
to send a less than quantal signal, and it also represents a more efficient granule 
recycling process. CFMA experiments show that midbrain neurons release 
dopamine multiple times from the same granule through this mechanism. 
Moreover, “kiss-and-run” exocytosis has also been observed in chromaffin, mast, 
and PC12 cells. While it is likely that swelling and dissociation of the intragranular 
matrix play a role in determining the fate of the fusion pore,107, 108 the species or 
processes that regulate whether a fusion pore reseals or dilates is currently 
unresolved. 
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Moreover, CFMA has been used to study the fusion pore stability and regulation. 
CFMA results show that both membrane proteins and lipids influence the 
exocytotic process. The previously mentioned SNARE proteins and their 
subgroups are often implicated in fusion pore formation models. Chapman and 
co-workers studied the exocytotic release from PC12 cells with genetically 
altered synaptotagmin using CFMA and concluded that a synaptotagmin-SNARE 
complex during exocytosis triggers formation of the fusion pore, and subgroups 
of synaptotagmin (I and IV) regulate the fate of that fusion pore.25 Amperomety 
studies accompanied by capacitance measurements on chromaffin cells109, 110 
demonstrated that both synaptotagmin I and VII may act as a Ca2+ sensor which 
regulates the fusion machinery and especially the latter one increases the 
release through kiss-and-run exocytosis.25 Moreover, syntaxin (another SNARE 
protein) has been shown as a necessary component of fusion pore formation and 
exocytosis. Synaptobrevin and SNAP-25 are the other two SNARE proteins 
whose function in fusion pore formation and stability is studied.111, 112 
 As some groups explore the role of protein components, others focus on the role 
of the lipids themselves. The effect of membrane phospholipid components and 
distribution on exocytosis has been studied using CFMA in both PC12 and 
chromaffin cells by adding exogeneous lipid species to the membrane.41, 113 
Results showed that phosphotidylserine, phosphatidylethanolamine, 
sphingomyelin, and phosphatidylcholine influence the exocytotic process either 
by changing the frequency, quantity, and/or kinetics of release. In addition to 
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membrane phospholipids, cholesterol is another major species found in the 
membrane and has both structural and functional importance in exocytosis. It has 
been shown that SNARE proteins are localized in cholesterol-rich lipid rafts, and 
removal of cholesterol disrupts these rafts, reducing exocytosis in PC12 cells, 
chromaffin cells, and platelets.23, 40 Since cholesterol stabilizes the negative 
curvature of the fusion pore, removal of cholesterol decreases fusion pore 
stability, and decreases the percentage of spikes with fusion pore (foot) events. 
Although CFMA measurements are a relatively new technique for single cell 
analysis, platelet CFM measurements have only been performed in the last few 
years. In 2008,6 FSCV was used to detect exocytosis of electroactive species 
from individual rabbit platelets and identify it as serotonin.  By maintaining the 
potential of the electrode at the oxidation potential of serotonin, CFMA was used 
to explore the biophysical properties of platelet exocytosis with the well-
understood serotonin redox reaction both in rabbit and human platelets. In the 
light of this work and follow-on studies, it is clear that, like other secretory cells, 
platelets also store granular content in a quantal fashion.6, 7 CFMA 
measurements performed at varying pH and osmolarity provided a better 
understanding of how serotonin is stored and how its secretion is regulated.7 
Moreover, in-depth analysis of varied cholesterol levels in platelet secretion 
showed that, besides being a ubiquitous lipid for membrane support, cholesterol 
regulates fusion pore stability during exocytosis via a biophysical, rather than 
biochemical, mechanism.23 Although invaluable knowledge has been acquired 
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since the first CFMA analysis of platelets, there are still a lot of questions to 
answer.    
1.8 Goals and Scope of Thesis 
Platelets are specialized secretory cells with three distinct types of granules 
loaded with important mediators for platelet function. Understanding the 
mechanism of platelet granular secretion is big interest not only for diagnostic but 
also for therapeutic purposes. Although ensemble assays that elucidate platelet 
secretory behavior provide insightful knowledge of platelet function at certain 
physiological conditions, since their output is the average response of more than 
millions of platelets, the heterogeneous platelet function is lost in the data. 
Moreover, the molecular dynamics of cell function is often not accessible with 
these techniques.  Amperometric recording of δ-granule secretion from single 
platelet brought a new perspective to studying platelet function and enabled 
analysis of δ-granule exocytosis with sub-ms time resolution. Since then, we 
learned how serotonin is stored in those granules and how extracellular 
environment modulate the secretory function. However, there is still a lot to learn. 
The main motivation of the work detailed in this thesis is to provide in depth 
understanding of platelet granular secretion by using CFMA.  
In chapter 2, I explore the similarities and differences of platelet secretion 
behavior among the platelets isolated from different species that have structural 
differences aiming to clarify the role of each component of platelet secretion. 
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Chapter 3 demonstrates the unrecognized function of (Dynamin related protein 1) 
Drp1 in platelet physiology. Although Drp 1 is a well-known protein involved in 
endocytosis, this work showed that Drp 1 also regulates platelet δ-granule 
secretion and thrombotic function. 
Chapter 4 elucidates the function of membrane phospholipids by taking 
advantage of variety of analytical techniques and study platelet aggregation and 
secretion at altered phospholipid concentrations. 
Chapter 5 compares a very well-studied secretory cell model, chromaffin cells 
with platelets in terms of the effect of cholesterol in their secretory behavior. 
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Chapter 2 
Comparison of Platelet δ- Granule Secretion from Different Species using 
Single Cell Measurements 
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2.1 Introduction 
Platelets are an important component of the hemostatic response, and their 
secretory behavior dictates much of their physiological function. α- granules, δ- 
granules and lysosomes are the chemical messenger storage units in platelets. 
While α- granules store important protein species, including adhesion molecules, 
growth factors, and chemokines, δ- granules supply critical ions and small 
molecules, including Ca2+, Mg2+, ADP, and serotonin from a polyphosphate 
matrix. Small numbers of lysosomes are also found in platelets to facilitate 
endosomal digestion.1 Similar to neurons, platelets release their granule content 
via exocytosis. 
Although platelets isolated from different species share some common features, 
there are also both structural and functional differences. 2-4 One of the major 
differences between platelets from different species is the presence or absence 
of a membrane-bound tubular system known as the open canalicular system 
(OCS).4, 5 Many species, including human, mouse, and rabbit platelets have an 
OCS whereas horse, cow and camel platelets are known to be devoid of this 
membrane structure. The OCS is likely an important determinant of granular 
secretion characteristics, serving as an anchor between the granular and plasma 
membrane. During exocytosis, granules can either fuse first to the OCS or to the 
plasma membrane to release their content.1, 5-7 These two distinct release 
behaviors may influence both secretion kinetics and the amount of the released 
chemical messengers. In platelets that have an OCS, different identity or amount 
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of stimulant may influence the order of membrane interaction, and thus, the 
secretion pattern. While these variations in chemical messenger delivery 
behavior will have significant implications in platelet biology, traditional platelet 
measurement methods, examining thousand to millions of platelets at a time, 
obscure these subtleties.  Herein, we employ a single cell analysis tool, carbon-
fiber microelectrode amperometry (CFMA), to reveal serotonin secretion behavior 
across species and with various stimulants. 8-10  
δ- granule secretion is critical in hemostasis;11 the procoagulant functions of δ-
granule contents, including both serotonin and polyphosphate, have been shown 
while ADP is known to induce platelet aggregation.12-14 Recently, CFMA has 
enabled detailed analysis of platelet δ-granular secretion with sub-ms time 
resolution, revealing the true kinetics of the secretory process and allowing 
distinction among heterogenous sets of platelets. 8-10  This study exploits CFMA 
to evaluate δ-granule release among different species, following exposure to 
various stimulants, to explore the role of the OCS and facilitate appropriate 
animal model choice. We considered rabbit and mouse as a model for the 
platelets with OCS, while cow platelets were examined as a model for non-OCS 
secretion behavior. In brief, the results show that, compared to mouse and rabbit, 
cow platelets secrete higher amounts of serotonin in spite of releasing fewer 
granules per stimulation event. This may indicate a role for the OCS in granular 
trafficking and docking.  Stimulation with ionomycin (which bypasses several 
steps relevant in physiological platelet stimulation) revealed more uniform 
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behavior between the OCS and non-OCS species compared to thrombin 
stimulation. Finally, membrane characteristics, including fusion pore formation 
and stability, varied among species and stimulants, revealing that the stability of 
the fusion event is stimulant dependent but that there is no correlation between 
the fusion pore stability and the presence of the OCS. Identifying the similarities 
and differences among platelets isolated from different species will facilitate 
understanding of the biophysical roles of the structural components of platelet 
secretion.  
2.2 Materials and Methods 
2.2.1 Isolation of platelets 
Blood was collected according to protocols approved by the University of 
Minnesota IACUC. Mid ear artery was used for rabbit blood draw to EDTA-
containing tubes. Mouse blood was collected via cardiac stick with syringes 
containing ACD. Cow blood was drawn from the tail to EDTA-containing tubes.  
In all cases, blood was diluted with addition of Tyrode’s buffer (NaCl, 137 mM; 
KCl, 2.6 mM; MgCl2, 1.0 mM; D-glucose, 5.6 mM; N-2-hydroxyethylpiperazine- 
N'-2-ethanesulfonic acid (HEPES) 5.0 mM; and NaHCO3, 12.1 mM with pH 
adjusted to 7.3) and centrifuged for 10 min at 500xg for rabbit and cow or 130xg 
for mouse platelets. The ( platelet rich plasma) PRP layer was separated, and 
washed platelets were obtained following a second 10 min centrifugation step 
(750xg for rabbit and cow, 500xg for mouse platelets). Pelleted platelets were 
resuspended in Tyrode’s buffer.  
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2.2.2 CFMA measurements 
Carbon-fiber microelectrodes were fabricated as was previously described. 8-10 
Amperometry experiments were performed with an Axopatch 200B potentiostat 
(Molecular Devices, Inc., Sunnyvale, CA) using low-pass Bessel filtering (5 kHz), 
a sampling rate 20 kHz, and gain amplification of 20 mV/pA, all controlled by 
locally written LabVIEW software and National Instruments data acquisition 
boards. Platelets were visually monitored during experiments with an inverted 
microscope equipped with phase contrast optics (40X magnification) (Nikon 
Instruments, Melville, NY). A drop of platelet suspension was added to the poly-
L-lysine-coated glass coverslips containing Tyrode’s buffer. As the platelets 
sedimented onto the coverslip, a CFM was placed on an individual platelet for 
measurement (Figure 2.1A). A stimulant-filled fire-polished capillary with an 
average tapered diameter of 10 µm was also placed close to the platelet of 
interest. Upon delivery of a 3 s bolus of either 10 U/mL thrombin solution in 
Tyrode’s buffer or 10 µM ionomycin in Tyrode’s buffer supplemented with 2 mM 
Ca2+, the platelet under the microelectrode was activated. Serotonin secreted 
from platelet δ-granules was oxidized at a potential of 700 mV vs Ag/ AgCl 
reference electrode, and data were recorded for 90s.  Each amperometric trace 
obtained from single platelet secretion was filtered at 500 Hz, and spike by spike 
analysis was performed using Mini Analysis program. Temporal resolution of the 
CFMA technique enables analysis of serotonin secretion from individual platelet 
granules, each appearing as an individual current spike in the amperometric 
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trace (Figure 2.1C). The amount of serotonin released from a single granule is 
determined based on the area under the peak (Q= mFn; where Q is the charge, 
m is number of moles of serotonin, F is the Faraday constant, and n is the 
number of electrons (2) transferred during serotonin oxidation). The kinetics of 
release are revealed based on the Trise and Thalf values for each current spike, 
indicating the kinetics of transition from fusion pore to full fusion and kinetics of 
the total release event, respectively. The number of platelets that were monitored 
per condition was 23 and 32 for mouse, 35 and 34 for rabbit, and 39 and 22 for 
cow for ionomycin and thrombin stimulation, respectively.   
2.2.3 Bulk HPLC analysis: 
Platelets in the PRP were counted and the diluted to 5x107 cells/mL in Tyrode’s 
buffer. 125 µL of the diluted PRP was put into a Millipore 96 well Multi Screen 
HTS filter plate with a 0.45 µm pore. Then, 125 µL of stimulant was added at 
twice the desired concentration to account for dilution.  After a five minute 
stimulation, the supernatant was spun down at 3000xg for five minutes, and 180 
µL of the supernatant was pipetted into a vial with 20 µL of 5 µM dopamine 
internal standard in 0.5 M perchloric acid. HPLC analysis was performed on an 
Agilent 1200 HPLC with an auto sampler containing a 5μm, 4.6 x 150mm C18 
column (Eclipse XDB-C18) attached to a Waters 2465 electrochemical detector 
with a glassy carbon-based electrode.  The working potential was set at 700 mV 
vs. an in situ Ag/AgCl reference electrode with a current range of 50 nA. The 
samples were sent through the HPLC with a flow rate of 2 mL/min in an aqueous 
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mobile phase mixture consisting of 11.6 mg/L of the surfactant sodium octyl 
sulfate, 170μL/L dibutylamine, 55.8 mg/L Na2EDTA, 10% methanol, 203 mg/L 
sodium acetate anhydrous, 0.1 M citric acid, and 120 mg/L sodium chloride. The 
ratio of serotonin to dopamine internal standard concentrations were then 
measured against a 5 point calibration curve made in advance using standard 
solutions of serotonin diluted in 0.5 M perchloric acid (ranging from 28 to 1000 
nM). The standard solutions were supplemented with 0.5 µM dopamine internal 
standard. 
2.2.4 TEM Measurements 
TEM samples of cow and mouse platelets were prepared by two step fixation of 
the platelets first with 0.1% gluteraldehyde (15 min) followed by centrifugation to 
pellet and then with 3% gluteraldehyde (30 min) in White’s saline as it is 
previously described. 15 After fixation, the cell pellet was exposed to 1% osmic 
acid at 4ºC for 1h. The platelet pellets were dehydrated slowly in a graded series 
of alcohol and embedded in the Epon resin. Thin sections were obtained with a 
diamond knife. Uranyl acetate was used for contrast enhancement. TEM images 
were analyzed by using ImageJ. 
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Figure 2.1 CFMA experimental setup and representative spikes. (A) Representative setup 
for CFMA measurements. CFM is (on the right) placed on a single platelet. Stimulation 
pipette (on the left) is placed close to the platelet. (B) Typical amperometric trace obtained 
from single platelet secretion. Each spike corresponds to single δ-granule release event. 
The bar under the trace shows time and the duration of the stimulation. (C) The 
parameters that are analyzed for single secretion events. (D) Representative spikes from 
mouse, rabbit and cow platelet exocytosis upon ionomycin (black) and thrombin (gray) 
stimulations. 
 
 
    
    
50 
 
2.3 Results 
2.3.1 Platelet Response to Different Stimuli 
δ-granule secretion upon exposure to two different agonists was evaluated. 
Figure 2.1D shows representative spikes corresponding to single release events 
upon thrombin (10U/mL) and ionomycin (10 µM) stimulations from different 
species. Although a numerical analysis is always needed, sometimes the shape 
of the representative trace can tell a lot about the amount and the kinetics of the 
secretion events. Except the mouse platelet, the spikes resulting from ionomycin 
and thrombin stimulation looked almost identical within the same species. 
Compared to the ionomycin stimulation spike, the representative spike for the 
thrombin-induced mouse platelet secretion is wider and shorter, indicating 
different secretion behavior that will be discussed later in detail. The 
representative spikes for cow platelets were both wider and larger than that of 
mouse and rabbit spikes. This indicates a slower but larger amount of serotonin 
release that will also be discussed below in detail.  
2.3.2. Comparison of the Quantal Secretion Between Different Species 
Regardless of the stimulation type, cow platelets released significantly more 
serotonin per release event (Figure 2.2A and Figure 2.2D) than either mouse or 
rabbit (Q= 331.2±26.0; Q= 275.7±25.1; Q=498±40.9 fC for mouse, rabbit and 
cow platelet secretion respectively upon ionomycin stimulation; Q=313.9±29.5; 
Q=271.5±21.7; Q=654.9±116.4 fC for mouse, rabbit and cow platelets secretion 
upon thrombin stimulation, respectively). Compared to cow platelets, both rabbit 
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and mouse platelets released a significantly higher number of discrete δ-granules 
per exocytotic event (N= 8.09±1.07; 9.61±1.31; 4.18±0.32 granules for mouse, 
rabbit and cow platelets, respectively, for ionomycin stimulation) that, when 
considered cumulatively, translates to more serotonin release per platelet ( # of 
moles of serotonin calculated from N*Q values by using Faraday’s Law  are 
13.8×10-18, 17.5×10-18,  9.6×10-18 moles of serotonin for mouse, rabbit, and cow 
platelets, respectively, for ionomycin stimulation).  This may indicate that the 
OCS doesn’t regulate the amount of release, but the number of vesicles 
trafficked and docked. Moreover, previous studies showed that α-granules in cow 
platelets fuse with each other during exocytosis, prior to fusion with the plasma 
membrane.16 A similar explanation for δ-granules would explain the higher Q and 
lower N values for cow platelet secretion. We analyzed the frequency of the 
distribution of the Q values (data not shown) expecting a bimodal distribution to 
show that where δ-granules fuse with each other ahead of plasma membrane 
fusion.  
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Figure 2.2 Comparison of the quantal release between the species upon 
ionomycin (A-C) and thrombin (D-F) stimulations. (A, D) Cow platelets 
release significantly higher number of serotonin molecules per release 
event. (B, E) Number of granules released per single platelet exocytosis. 
(C, F) N*Q represents the total amount of serotonin secreted from single 
platelet. (* for p<0.05, ** for p<0.01, *** for p< 0.001) 
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However, frequency analysis did not show such a distribution; a single non-
Gaussian distribution similar to the previously reported distribution for rabbit 
granular release was observed instead9 this makes the possibility of fusion of two 
δ-granules unlikely. TEM images were used to analyze the size of δ-granules of 
cow and mouse platelets (Figure 2.3). Results showed that cow platelets not only 
have larger δ- granules but the dense core of the δ-granules where the most of 
the serotonin is stored is significantly bigger in cow platelets (average granule 
diameter is 229.3±6.1 nm for mouse platelet δ-granule, 341.0±11.1 for cow 
platelet granule. This increases the possibility that more serotonin is stored in 
cow platelet granules. 
As it is evidenced by Ewing and colleagues, it is not necessarily true that the 
entire content of a granule is released upon stimulation; in fact, PC12 cells, a 
model exocytotic cell, only release 45% of their vesicular content. 17 Herein, we 
evaluated the percentage of total δ-granule content release using bulk HPLC 
measurements by either lysing the cells with HClO4 and analyzing the total 
serotonin content, or by exposing the cells to 10 U/ml thrombin or ionomycin and 
measuring the released content. Figure 2.4 data shows the percent lysis data for 
each species and stimulant.  
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Figure 2.3 TEM analysis of cow and mouse platelets. Cow platelets have 
significantly larger δ-granules with higher granule diameter (A) and dense 
core diameter (B). TEM images of a single mouse platelet (C) and cow 
platelet (D). Red bars represent 1000nm. (***p<0.001). 
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Figure 2.4 Bulk serotonin analysis using HPLC.  % of the total serotonin 
secreted with (A) ionomycin stimulation or (B) thrombin stimulation.  
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It is clear that more serotonin is released in all species upon thrombin activation 
as compared to ionomycin activation.  In both rabbit and mouse platelets, the 
granules released more than 50% of the total serotonin content; however, only 
27.53 and 41.06% of the serotonin was released from cow platelets with 
ionomycin and thrombin stimulation, respectively (p<0.001) .Use of human 
thrombin cannot be the reason for this behavior since it has been shown 
previously that human thrombin was 89% homologous to cow thrombin, and cow 
platelets are known to respond similarly to human and cow thrombin.4 This may 
indicate that the reduced cow platelet secretion, compared to that by rabbit and 
mouse platelets, may not be due to the effectiveness of the stimulant but 
efficiency of the response to the stimulant, perhaps related to the use of the 
OCS. Comparison of secretion kinetics may yield insight on this matter. 
 
2.3.3 Comparison of the Kinetics of Release Between Different Species 
Trise values measure the time required for transition from 10% to 90% of the peak 
maximum, representing the time required for transition from the initial pore 
opening to full fusion. During this time, the soluble (non-polyphosphate-
associated) serotonin present in the granules is released.18  T1/2 is a measure of 
the total time of a serotonin secretion event which can be influenced by the 
opening of the fusion pore, the size of the expanded pore, dissolution of the 
matrix-bound serotonin, and diffusion of that serotonin into the extracellular 
space.  When stimulated with ionomycin, cow platelets showed slower release 
57 
 
kinetics than either rabbit or mouse platelets (higher Trise and T1/2 values)   
(Figure 2.5). This could be attributed to the larger number of serotonin molecules 
secreted or to less efficient extrusion of the molecules.  Mouse and rabbit 
platelets showed comparable release kinetics upon ionomycin stimulation (T1/2= 
13.95±1.08 and 14.70±1.6 ms  for mouse and rabbit, respectively). Thrombin, 
however, induced distinct secretion behavior for each species. Although mouse 
and rabbit platelets release similar amounts of serotonin from δ-granules, mouse 
platelet secretion was much slower than that from rabbit platelets (T1/2= 
20.34±1.20; and 15.42±1.21 ms for mouse and rabbit, respectively p=0.0041). 
This may be due to a difference in sensitivity to the thrombin stimulation which 
influenced the secretory kinetics.  Cow platelet secretion kinetics were slower in 
thrombin-induced stimulation with a T1/2 value of 26.82± 2.09 ms.   
 
2.3.4 Comparison of Fusion Events Between Species 
During platelet granular secretion, fusion of the granular membrane with plasma 
membrane gives rise to formation of a fusion pore of limited stability. Fusion pore 
formation and stability affects both the quantal release and kinetics of the 
release.19, 20 In amperometric traces, the fusion pore can be identified as a subtle 
increase in the current due to the diffusion of soluble serotonin as the fusion pore 
opens (Figure 2.1.C); this current feature is commonly known as a “foot.”18  
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Figure 2.5 Comparison of the secretion kinetics with either (A, B) ionomycin or 
(C, D) thrombin stimulation. (A, C) Larger Trise values from cow platelet secretion 
indicate slower transition to maximal release. (B, D) Duration of the total secretion 
was longest in cow platelets regardless of the stimulant. Although the T1/2 values 
from rabbit and mouse platelets were similar in the ionomycin condition, thrombin 
stimulation resulted in higher T1/2 values, and thus, slower release from mouse 
platelets compared to rabbit platelets. (*for p<0.05, ** for p<0.01, *** for p< 0.001) 
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The analysis of the foot events among amperometric spikes shows that the 
stability of the fusion pore is highly dependent on the mechanism of the activation 
(Figure 2.6).  Mouse platelets showed the highest percentage of fusion pore 
events when they were activated with ionomycin (18.09±3.60 % of the mouse 
secretion events showed foot feature as opposed to 9.45±2.00 and 13.50±2.54 
% fusion pore events in rabbit and cow exocytosis, respectively). Stimulation with 
thrombin caused a drastic decrease in secretion events initiated through a stable 
fusion pore (9.29±2.28 % events with foot). On the other hand, thrombin 
stimulation caused a significant increase in the stability of the fusion pore of 
rabbit and cow platelet dense granule secretion (%Foot= 15.01±2.12 and 
23.72±5.08 for rabbit and cow platelets, respectively).  This indicates that fusion 
pore stability is both species and stimulant dependent, and there is no correlation 
between the presence of OCS and fusion pore occurrence. 
 
2.4 Discussion 
Addressing the differences among platelets of different species will help clarify 
the role of each component of platelet secretion and will promote better targeting 
strategies to control platelet function in many physiological processes. One of the 
major structural differences between platelets from different species is the 
presence of a system of tunneling invaginations from the plasma membrane 
known as the OCS.2, 4, 7 
 
60 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 Fusion pore analysis. (A) With ionomycin stimulation, mouse 
platelets have higher % events with foot (B) Thrombin stimulation resulted 
in the most stable fusion pores in cow platelets compared to mouse and 
rabbit platelet. (*p<0.05) 
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Work done by various groups has demonstrated that the OCS influences platelet 
morphology during activation and that the presence of the OCS helps platelets 
interact with surfaces better by providing platelet spreading and pseudopodia 
formation.16, 21 In contrast, platelets without an OCS kept their discoid shape 
even after 1 h interaction with surfaces.21 Moreover, it was shown that the OCS 
membrane contains SNARE proteins, including syntaxin 2, SNAP 23 and VAMP 
3 and is involved in platelet granular secretion by serving as intermediate fusion 
sites for the granules before plasma membrane fusion.7 Very active hemostatic 
function of  camel platelets (lacking an OCS) raises the question of the actual 
need and use of these tubular structures in platelets.2 Whiteheart group showed 
the proteins that regulate the actin cytoskeleton are expressed at higher levels in 
OCS-containing platelets.4 This brought up the possibility of OCS involvement in 
granule trafficking and docking.  Clearly, more insight is needed into the actual 
influence of OCS in platelet function. Furthermore, diversity in the response to a 
certain agonist within the OCS containing species3, 4, 22 necessitates a more 
careful look at the platelet behavior in different species. Although previous 
studies with TEM images and bulk assays provided useful insights about the 
structural and functional differences among platelets of different species, a more 
detailed analysis of kinetics of the release was not possible until CFMA 
measurements of platelet δ-granule secretion was available.8 This work aims to 
address this need in platelet biology by studying secretion from both OCS-
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containing (mouse and rabbit platelets) and OCS- deprived (cow platelets) 
platelets by CFMA. 
Thrombin is a strong stimulant of PAR -mediated platelet activation.23 Ionomycin 
is a calcium carrier that not only shuttles extracellular calcium into the cells, but 
also immobilizes the calcium in δ- granules of platelets, resulting in elevated 
intracellular calcium levels and thus, triggering exocytosis.8, 9 Upon exposure to 
ionomycin or thrombin, cow platelets released more serotonin per secretion 
event than mouse or rabbit platelets; in fact, the Q values that reveal the amount 
of serotonin secreted from individual granules were almost double those from 
rabbit and mouse platelet exocytosis (Figure 2.2). Previous work showed that 
platelet serotonin storage is quantal 9 which means same concentration of 
serotonin is stored in each δ-granule. Thus, cow platelet granules should be 
twice as large as of mouse and rabbit platelets to provide concentrations of 
serotonin similar to rabbit and mouse platelet granules. Moreover, It is known 
that cow platelet α-granules fuse with each other and then the plasma membrane 
during exocytosis.16 Our results show that a similar mechanism is possible for δ-
granule secretion. The histogram showing the frequency of the distribution of the 
Q values did not show bimodal distribution which makes the fusion of the δ- 
granules with each other less likely. The large granule size of cow platelets 
compared to platelets from other species was reported by White et. al. and more 
likely is the reason for the high Q values obtained.16  Analysis of the size of  the 
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cow and mouse δ-granules supported the previous report showing that  cow δ-
granules is much larger than mouse platelets. 
Measurement of total vs. secreted serotonin with HPLC allowed the analysis of 
the efficacy of the secretion.  % release from cow platelets was drastically lower 
than mouse and rabbit platelets. Furthermore, the parameters that were used to 
determine the kinetics of the secretion event (T1/2 and Trise values) were 
significantly higher for cow platelet. Although the higher T1/2 and Trise values may 
be due to the higher amount of serotonin secreted, it is possible that the absence 
of the tubular structure retarded secretion kinetics. All these observations 
indicate that OCS may not be necessary for the secretion but it indeed influences 
the efficacy of the release.  
Time resolution of the CFMA technique enables observation of the fusion pore 
events in the case of a stable fusion pore formation.10 The stability of fusion pore 
is strongly dependent on membrane properties and dissolution of the releasates 
from the granular matrix.24 Upon activation, the membrane reorganizes itself to 
accommodate proteins at the site of fusion. This includes redistribution of 
phospholipids in the inner and outer leaflet of the membrane and migration of the 
SNARE proteins as well.25, 26 Ionomycin and thrombin stimulations showed 
different trends in the foot parameters. This may be due to the different signaling 
pathway involved in the activation through ionomycin and thrombin affecting the 
membrane organization and hence, the stability of the fusion pore differently in 
different species.  
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In conclusion, by using CFMA and HPLC, and TEM we have demonstrated the 
similarities and differences in platelet δ-granule secretion behavior of platelets 
from different species. Although OCS is an important factor needed for efficient 
secretion, the differences between rabbit and mouse secretory behavior shows 
that the absence or presence of the OCS is not the major determinant of 
chemical messenger secretion behavior.  
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Chapter 3 
Dynamin-Related Protein-1 Controls Fusion Pore Dynamics During Platelet 
Granule Exocytosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from: 
Koseoglu  S, Dilks J, Peters C, Fitch J,  Fadel  N, Jasuja R, Italiano JE,  Haynes 
CL, Flaumenhaft R. Dynamin-related protein-1 controls fusion pore dynamics 
during platelet granule exocytosis. Submitted. 
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3.1 Introduction 
Platelet granules are required for normal hemostasis and contribute to 
pathological thrombus formation. Platelet granule exocytosis has also been 
implicated in numerous other physiological functions, including inflammation, 
microbial host defense, angiogenesis, and wound healing. Platelet granule types 
include α-granules (50-80 granules/platelet), δ-granules (3-6 granules/platelet), 
and lysosomes (0-3 granules/platelet). These granules release their contents 
following stimulation of receptors on the platelet surface. Although much has 
been learnt about the proximal signal transduction mechanisms that mediate the 
release of granule contents following stimulation of surface receptors, 
considerably less is known about the distal mechanisms that facilitate granule 
exocytosis.1 
Exocytosis of platelet granule contents requires the fusion of granule membranes 
with plasma membranes or membranes of the open canalicular system.2 The 
release of contents is thought to occur through a fusion pore. 
Electrophysiological techniques have been used to study the formation, 
expansion, and collapse of the fusion pore in neurons and neuroendocrine cells. 
Yet the mechanisms regulating the platelet fusion pore are poorly understood, 
and the proteins that control platelet fusion pore dynamics have not been 
identified. Platelet fusion pore dynamics have been difficult to study by standard 
electrophysiological methods because of platelets’ small size and atypical 
membrane system. Single-cell amperometry, however, has sufficient temporal 
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and spatial resolution to evaluate fusion pore dynamics in live platelets and has 
recently been used to study quantal release of serotonin from individual δ-
granules.3-6 Amperometric tracings of platelet δ-granule release demonstrate 
features previously observed only in nucleated cells, indicating that stable fusion 
pore formation, fusion pore expansion, and ‘kiss-and-run’ exocytosis occur in 
platelets. We have previously used amperometry of individual platelets to 
evaluate mechanisms of platelet membrane pore dynamics .3, 5-7   
 
We now use single-cell amperometry to study the role of dynamin-related protein 
1 (Drp1) in platelet granule release. Drp1 belongs to the dynamin superfamily, a 
group of large GTPases that act as mechanoenzymes and demonstrate 
oligomerization-dependent GTPase as well as membrane modeling activities.8 
Drp1 is most widely known for its role in mediating mitochondrial fission and 
fusion. We demonstrate that platelets contain Drp1 and that Drp1 is 
phosphorylated upon platelet activation. Blocking Drp1 inhibits platelet granule 
exocytosis and impairs fusion pore stability. Inhibition of Drp1 also interferes with 
platelet accumulation during thrombus formation in vivo. These studies 
demonstrate a heretofore unrecognized function of Drp1 in platelet physiology. 
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3.2 Materials and Methods 
3.2.1 Platelet Preparation  
For human platelets, blood was obtained from healthy donors who had not 
ingested aspirin or NSAIDs in the 2 weeks prior to donation. Platelets were 
isolated by centrifugation followed by isolation of washed platelets from platelet-
rich plasma. For single cell amperometry experiments, blood was drawn from the 
midear artery of New Zealand rabbits (Bakkom Rabbitry) according to approved 
University of Minnesota IACUC protocol #0802A27063. Isolation of washed 
rabbit platelets in Tyrode’s buffer (NaCl, 137 mM; KCl, 2.6 mM; MgCl2, 1.0 mM; 
D-glucose, 5.6 mM; N-2-hydroxyethylpiperazine- N'-2-ethanesulfonic acid 
(HEPES) 5.0 mM; and NaHCO3, 12.1 mM with pH adjusted to 7.3) was 
previously described9 
3.2.2 Single-cell Amperometry  
Amperometry experiments were performed with an Axopatch 200B potentiostat 
(Molecular Devices, Inc.) controlled by locally written LABVIEW software. 
Fabrication of carbon-fiber microelectrodes and the experimental instrumentation 
have been previously described.3, 5, 10 Rabbit platelets were used for these 
experiments because they have a substantially higher number of δ-granules per 
platelet than human platelets. To begin a measurement, a drop of rabbit platelet 
suspension was added to the experimental chamber that contained either 10 µM 
mdivi-1 (Tocris), or 10 µM compound E (generous gift of Dr. Jodi Nunnari and Dr. 
Ann Cassidy-Stone) in Tyrode’s buffer (prepared from stock solutions in DMSO) 
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or the same volume of DMSO in Tyrode’s buffer for experimental and control 
conditions, respectively. Platelets were allowed to sediment on poly L-lysine-
coated coverslips for 15 minutes before amperometry measurements. One 
platelet at a time was stimulated with a 3 s bolus of thrombin solution in Tyrode’s 
buffer (10 U/mL), and the amperometric response was recorded for 60 s. Data 
were analyzed as has been previously described5 and reported as mean+SEM; t-
tests were used to identify statistically significant differences compared to the 
control condition. Amperometric measurements were recorded from 107 platelets 
for control condition, 39 platelets for mdivi-1 condition, and 31 platelets for the 
compound E condition. 
3.2.3 Thrombus Formation Model 
Intravital video microscopy of the cremaster muscle microcirculation was 
performed as previously described.11 Mouse anti-human fibrin II β-chain 
monoclonal antibody was purified over protein G-Sepharose (Invitrogen) from a 
59D8 hybridoma cell line12 and labeled with Alexa Fluor 488 (Invitrogen). Digital 
images were captured with a Cooke Sensicam CCD camera (The Cooke 
Corporation) connected to a VS4-1845 Image Intensifier GEN III (Video Scope 
International). Injury to a cremaster arteriolar (30-50 μm diameter) vessel wall 
was induced with a Micropoint Laser System (Photonics Instruments) focused 
through the microscope objective, parfocal with the focal plane and tuned to 440 
nm through the dye cell containing 5 mM coumarin in methanol. Data were 
captured digitally from two fluorescence channels, 488/520 nm and 647/670 nm. 
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Data acquisition was initiated both prior to and following a single laser pulse for 
each injury. The microscope system was controlled and images were analyzed 
using Slidebook (Intelligent Imaging Innovations).  
3.2.4 Image Analysis 
For each thrombus generated, a rectangular mask was defined that included a 
portion of the vessel upstream of the site of injury. The maximum fluorescence 
intensity of the pixels contained in this mask was extracted for all frames (pre- 
and post-injury) for each thrombus. The mean value calculated from the maximal 
intensity values in the mask for each frame was determined and used as the 
background value. Finally, for each frame the integrated fluorescence intensity 
was calculated as per following equation: 
Integrated fluorescence intensity = sum intensity of signal – (mean of the 
maximal background intensity X area of the signal).  
This calculation was performed for all frames in each thrombus and plotted 
versus time to provide the kinetics of thrombus formation. For multiple 
fluorescence channels, calculations of background were made independently for 
each channel. The data from 25-30 thrombi were used to determine the median 
value of the integrated fluorescence intensity to account for the variability of 
thrombus formation at any given set of experimental conditions. 
3.2.5 Statistical Analysis  
A value representing area under the curve was calculated for each curve 
generated by measurement of fluorescence following laser injury of an arteriole. 
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A Mann-Whitney test was used for statistical comparison of data sets comprised 
of the indicated number of thrombi formed under each indicated 
condition. P values of 0.05 or less were considered statistically significant and 
are indicated. Statistical analyses were performed using Prism software package 
(version 4; GraphPad). 
3.2.6 Immunoblot Analysis 
Platelet lysates were prepared by lysis of human platelets (2 x 108/ml) in sample 
buffer. To prepare cytosol and membranes, platelets were incubated with 15 
U/mL streptolysin-O (Sigma, MO) overnight and subsequently pelleted at 1000g 
for 15 minutes. The cytosol fraction was collected and the pellet was washed in 
PIPES/EGTA/KCl buffer (25 mM PIPES, 2 mM EGTA, 137 mM KCl, 4 mM NaCl, 
0.1% glucose, pH 6.4). Proteins in cytosol and membranes were then solubilized 
in sample buffer and separated by SDS-PAGE. Immunoblotting was performed 
using antibodies directed against dynamin 1, dynamin 2, Drp1 (Abcam), 
phospho-Drp1 serine 616 (Cell Signaling Technology), and phospho-Drp1 serine 
637 (Cell Signaling Technology) and FITC-labeled or HRP-labeled secondary 
antibodies (Jackson Immunorearch Laboratories). FITC-labeled or HRP-labeled 
secondary antibodies were visualized using fluorescence detection on a Typhoon 
9400 Molecular Imager (GE Healthcare) or chemiluminescence using an X-
OMAT 2000A Processor (Kodak), respectively. 
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3.2.7 Immunogold Electron Microscopy  
For preparation of cryosections, isolated human platelets were fixed with 4% 
paraformaldehyde in 0.1 M Na phosphate buffer, pH 7.4. After 2 hours of fixation 
at room temperature, the cell pellets were washed with PBS containing 0.2 M 
glycine. Before freezing in liquid nitrogen, cell pellets were infiltrated with 2.3 M 
sucrose in PBS for 15 minutes. Frozen samples were sectioned at 120°C, and 
the sections were transferred to formvar-carbon coated copper grids and floated 
on PBS until the immunogold labeling was carried out. The gold labeling was 
carried out at room temperature on a piece of parafilm. Anti-Drp1 antibody 
(Abcam) and Protein A gold were diluted with 1% BSA. The anti-Drp1 antibody 
recognized a single band of the appropriate molecular weight in immunoblot 
staining of platelet lysates (Fig. 1A,B). Grids were floated on drops of 1% BSA for 
10 minutes to block for nonspecific labeling, transferred to primary antibody, and 
incubated for 30 minutes. The grids were then washed, transferred to Protein A 
gold for 20 minutes, and washed in PBS followed by double distilled water. 
Contrasting/embedding of the labeled grids was carried out on ice in 0.3% uranyl 
acetate in 2% methyl cellulose for 10 minutes. The grids were examined in a 
Tecnai G2 Spirit BioTWIN transmission electron microscope (Hillsboro, OR) at 18 
500 magnification at an accelerating voltage of 80 kV. Images were recorded 
with anAMT 2k CCD camera.13 Control samples using a non-immune antibody 
demonstrated no staining. 
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3.2.8 Confocal Microscopy 
For colocalization measurements, human platelet mitochondria were labeled by 
incubation of the PRP with 100 nM Mitotracker Red (Life Technologies) for 45 
min at 37 ºC. To label δ- granules, platelets were incubated with (10µM) Oregon 
Green 488 BAPTA-1 Dextran (Invitrogen) at room temperature for 30 min. PRP 
with a platelet count of 107platelets/mL was then added to poly-L-lysine 
containing coverslips. Adhered platelets were fixed and permeabilized with 4% 
formaldehyde (in Tyrode’s buffer) and 0.2% Triton X-100, respectively. After 
incubating with IF blocking buffer (10% FCS, 1% BSA and 0.05% sodium azide 
in PBS) overnight, platelets were labeled with mouse anti-human Drp-1 antibody 
(Abcam). FITC-conjugated goat anti-mouse IgG antibody (Abcam) used as a 
secondary antibody for imaging the Drp-1.14 An Olympus FluoView F1000 upright 
confocal microscope was used for capturing images. Sequential scanning with 
488 and 543 nm lasers enabled selective imaging of the two fluorescent labels 
(mitotracker red and FITC) without spectral crosstalk. ImageJ, with the Mander’s 
coefficients plugin, was used for colocalization analysis. 
3.2.9 Flow Cytometry 
Gel-filtered platelets (10 µL; [0.5-1 x 108/mL]) were incubated with the indicated 
concentrations of inhibitor for 20 minutes. Samples were then exposed to 5 µM 
SFLLRN (thrombin receptor activating peptide) and analyzed by flow cytometry 
using a Becton Dickinson FACSCalibur flow cytometer as previously described.15  
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PE-conjugated antihuman P-selectin (BD Biosciences) was used to detect P-
selectin exposure. For evaluation of mitochondrial membrane potential, platelets 
were incubated with 1µM JC-1 (Invitrogen) for 10 minutes and either buffer alone, 
mdivi-1, or actimycin A (Sigma) for 20 minutes. Platelets were then exposed to 
either buffer or SFLLRN for 20 minutes and evaluated by flow cytometry. 
Fluorescent channels were set at logarithmic gain and 1 x 104 particles were 
acquired for each sample. A 530/30 band pass filter was used to measure FL1 
fluorescence and a 585/42 band pass filter was used to measure FL-2 
fluorescence. Data were analyzed using CellQuest software (BD Biosciences) on 
a MacIntosh PowerPC (Apple). Data using JC-1 are represented using the ratio 
of FL2/FL1 as previously reported.16  
3.2.10 Detection of Adenine Nucleotide Release 
A luciferin-luciferase detection system was used to quantify ADP/ATP release to 
monitor bulk δ- granule secretion.17 For these experiments, 9 µL human platelets 
(0.5-1 x 108/mL) were incubated in the presence or absence of mdivi-1 and then 
stimulated with SFLLRN. Samples were then incubated with 1 µL luciferin-
luciferase (final concentration of 3 mg/mL) at the indicated time following addition 
of agonists. Chemoluminescence was quantified using a luminometer (TD 20/20; 
Turner Design).  
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3.3 Results 
3.3.1 Dynamins in Platelets 
Dynamins are a superfamily of large GTPases that serve a wide range of 
membrane shaping functions.8 Their expression and function in platelets is not 
well-understood. Megakaryocytes have previously been shown to express 
dynamin 3.18, 19 However, whether other dynamins and dynamin-related proteins 
are present in platelets has not been assessed. We therefore evaluated platelet 
lysates for dynamin 1, dynamin 2, and Drp1. Dynamin 1 was not identified under 
the conditions of our assay. In contrast, dynamin 2 and Drp1 were recognized as 
single bands with apparent molecular weights of 100 kD and 80 kD, respectively 
(Figure 3.1A). No additional bands were detected in immunoblots of platelet 
lysates. To evaluate for the presence of Drp1 in platelet cytosol, platelets were 
permeabilized with streptolysin-O and subsequently pelleted. Evaluation of 
platelet cytosol and membranes demonstrated Drp1 in both fractions (Figure 
4.1B), indicating that a portion of platelet Drp1 is cytosolic. Evaluation of 
activation-dependent phosphorylation of platelet Drp1 using phosphorylation site 
specific antibodies demonstrated that Drp1 is phosphorylated at serine 616 
following incubation with SFLLRN to activate PAR1 and at serine 637 following 
incubation with forskolin to activate adenylyl cyclase (Figure 4.1C). Immunogold 
electron microscopy was performed to further define the localization of Drp1 in 
platelets. Studies using a non-immune antibody demonstrated no staining. These 
results show that Drp1 is found in platelets, is phosphorylated in an activation-
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dependent manner, and localizes to both membranes and cytosol. Moreover, 
confocal analysis showed that Drp1 colocalizes both in mitochondria and platelet  
δ-granules. 
3.3.2 Drp1 Functions in Platelet Granule Exocytosis 
Dynamins have a well-established role in endocytosis,8, 20, 21 associating with the 
stalk of the maturing endocytotic vesicle and catalyzing vesicle scission. More 
recently, dynamins have been shown to function in granule exocytosis of 
nucleated cells.22-26 To evaluate whether dynamins function in platelet granule 
exocytosis, we tested the effect of the dynamin inhibitors, dynasore and 
MiTMAB, on exocytosis using surface expression of P-selectin as a marker of α-
granule release (Fig.3.3). Dynasore blocked agonist-induced P-selectin surface 
expression with an IC50 of approximately 20 µM (Fig.3.3), close to its IC50 for 
recombinant dynamin in a GTPase assay.27 MiTMAB also inhibited P-selectin 
surface expression with an IC50 of approximately 20 µM (Fig. 3.3). These results 
indicate a role for dynamins in platelet granule exocytosis. 
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Figure 3.1 Detection and localization of Drp1 in platelets.  
(A) Human platelet lysates were evaluated for dynamin 1 (DNM1), dynamin 2 
(DNM2), and dynamin-related protein-1 (Drp1) as indicated. (B) Platelet 
cytosol and membranes were evaluated for Drp1. (C) Platelet were incubated 
with either 1) buffer alone, 2) 5 µM SFLLRN, or 3) 10 µM forskolin. Lysates 
were then evaluated using either an anti-Ser616 Drp1 phosphorylation site 
specific antibody (phosphor-Ser616 Drp1), an anti-Ser637 Drp1 
phosphorylation site specific antibody (phosphor-Ser637 Drp1), or an 
antibody to detect total Drp1 (Drp1). (D) Immunogold staining of resting 
platelets demonstrates Drp1 associated with plasma membrane (black 
arrows), granule membranes (white arrows), and cytosol (black arrowheads). 
Scale bar, 100 nm. 
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Figure 3.2 Colocalization of Drp1 with platelet mitochondria and δ-
granule.  
Double staining confocal immunofluorescence microscopy of resting human 
platelets demonstrates colocalization of anti-Drp1 antibody with the 
mitochondrial stain, Mitotracker Red and δ-granule stain BAPTA-1. This 
representative image shows staining of (A) Drp1, (B) mitochondria, and (C) the 
merged images. Scale bar 5 m. Analysis of colocalization demonstrate a 
Pearson’s coefficient of 0.675+0.025, an M1 value (Drp1 associated with 
mitochondria) of 0.428+0.038), and an M2 value (mitochondria associated with 
Drp1) of 0.731+0.067. (D) δ-granule, (E) Drp1, (F) the merged images. 
Analysis of colocalization demonstrate a Pearson’s coefficient of 0.721+0.037, 
an M1 value (δ-granule associated with Drp1) of 0.579+0.047), and an M2 value 
(Drp1 associated with δ-granule) of 0.707+0.033. Staining with non-immune 
antibody showed no fluorescence, and no crossover was observed between 
fluorescence channels. 
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Dynasore and MiTMAB have been used widely to assess the role of dynamin 
family proteins in cell function.27, 28 However, they are general inhibitors of 
dynamins and cannot be used to assess the role of specific dynamin subtypes in 
exocytosis.  
Drp1 is widely known for its role in mitochondrial fission29-32 and fusion.33 
However, a role in degranulation has also been described.34 To determine 
whether Drp1 functions in granule exocytosis, we used the well-characterized 
Drp1 inhibitor, mitochondrial division inhibitor-1 (mdivi-1).  Mdivi-1 selectively 
blocks Drp1, but not other dynamin isoforms and acts outside of the GTP binding 
site.35 This inhibitor blocked PAR1-mediated α-granule release with an IC50 of 
approximately 10 µM (Fig. 3.4A), similar to its IC50 for inhibition of recombinant 
Drp1 in a GTPase assay.35   
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Figure 3.3. Inhibition of dynamins blocks α-granule secretion secretion. 
Human platelets were incubated in the presence of either (A) vehicle alone, (B) 
dynasore, or (C) MiTMAB and subsequently exposed to buffer (black) or 5 µM 
SFLLRN (gray). P-selectin surface expression was subsequently evaluated by 
flow cytometry. (D) Both dynasore and MiTMAB inhibited PAR1-mediated P-
selectin expression in a dose-dependent manner (n = 3 + S.D.). 
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Figure 3.4 Role of Drp1 in α-granule and δ-granule exocytosis. 
(A) Platelet P-selectin surface expression in response to 5 µM SFLLRN was 
assayed in the presence of the indicated concentrations of either mdivi-1 
(black circle), compound D (black square) or compound E (open circle). Data 
are representative of 3 experiments + S.D. (B) Platelets were incubated with 
the indicated concentrations of mdivi-1 for 20 minutes prior to addition of 5 
µM SFLLRN. Release of adenine nucleosides was subsequently monitored 
using a luciferin-luciferase assay. Data are representative of 3 similar 
experiments. 
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One method to assess the selectivity of a small molecule for a particular protein 
target is to use compound analogs that vary in their ability to inhibit the target and 
determine whether or not their activity is replicated in the cellular system of 
interest. Analogs of mdivi-1 were used to assess whether Drp1 is the relevant 
target of mdivi-1 in platelet granule exocytosis. Compound D, an analog with 
potency equal to that of mdivi-1 against recombinant Drp1 in a GTPase assay;35  
demonstrated similar potency to mdivi-1 in an assay of α-granule release (Fig. 
3.4A). Compound E was substantially less potent than mdivi-1 against 
recombinant Drp1 in a GTPase assay, demonstrating only approximately 45% 
inhibition at 50 µM.35  Therefore, if Drp-1 is the relevant target for mdivi-1 in the 
exocytosis system, then compound E would demonstrate significantly less 
activity than mdivi-1. Compound E was significantly less active in inhibiting 
-granule release (Fig. 3.4A). To determine whether Drp1 functions in δ-
granule release as well as α-granule release, we evaluated the role of mdivi-1 on 
adenine nucleoside release using a lucerifase-based assay. δ- granule release 
was inhibited by mdivi-1 with an IC50 of approximately 10 µM (Fig. 3.4B). These 
results indicate a role for Drp1 in platelet granule exocytosis. 
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Figure 3.5 Role of Drp1 in kinetics of the platelet granule release.  
(A) Representative amperometric traces of rabbit platelet δ-granule release in the 
presence and absence of mdivi-1. The heavy bar beneath the tracings indicates 
the time and the duration of the thrombin stimulation. Insets: The distinct spike 
shapes for control (upper) and mdivi-1 (lower) conditions depicted in the 
millisecond time scale demonstrate different serotonin release kinetics. Mdivi-1 
(10µM) did not influence quantal release (B), the number of granules released per 
cell (C), or the time required for transition from fusion pore to full fusion (Trise) (D). 
However, the total time required for the release event (T1/2) was longer for platelets 
exposed to mdivi-1 (p<0.001) (E). Data represent the average + S.E.M. of 107 
control tracings and 39 tracings from platelets exposed to mdivi-1.  
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3.3.3 Drp1 Controls Platelet Fusion Pore Dynamics 
Drp1 functions in mitochondrial dynamics that contribute to granule secretion in 
mast cell exocytosis, synapses, and insulin-secreting cells.34, 36, 37 We used 
single-cell amperometry to evaluate, with sub-millisecond resolution, the effect of 
mdivi-1 on the release of serotonin from rabbit platelets (Fig. 3.5A). Statistical 
analyses of multiple tracings showed that 10 µM mdivi-1 had no effect on the 
quantal concentration of released serotonin (Fig. 3.5B) or the number of fusion 
events per platelet (Fig. 3.5C), which enabled unambiguous evaluation of the 
change in fusion pore behavior and kinetics of release. Results showed that 
although 10 µM mdivi-1 did not affect the time required for transition from fusion 
pore to maximal release (Trise) (Fig. 3.5D), it changed the kinetics of the total 
release event (Fig. 3.5E). The prolonged spike width in amperometric tracings in 
samples exposed to mdivi-1 indicated that mdivi-1 reduced the efficiency of 
serotonin release through the fusion pore. Time of half maximal release (T1/2) 
was 14.97±0.81 ms for control and 23.00±1.70 ms for mdivi-1 conditions (Fig. 
3.5E). This effect can be observed in figure 3.5A (see inset), where the 
representative spikes for each condition are shown above the tracings; mdivi-1 
treated cells produced wider (larger T1/2) and smaller amplitude spikes (since the 
Q values are similar) upon release of serotonin. Amplitude analysis 
demonstrated a mean amplitude of 16.58+1.35 pA in control samples compared 
with 8.96+0.93 pA in samples incubated with mdivi-1 (p=0.0004). In contrast, 
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compound E had no effect on T1/2 (Figure 3.6) This result demonstrates that 
mdivi-1 impairs efficient extrusion of serotonin from platelet δ-granules. 
Additional characteristics of amperometric tracings were evaluated to assess the 
role of Drp1 on the rate of δ- granule release and on fusion pore stability (Fig. 5). 
Cumulative frequency analyses indicate how efficiently granules are trafficked, 
docked, and fuse upon stimulation.7 Since the percent of granules released over 
time does not change upon mdivi-1 treatment (Fig.3.7B), it is unlikely that mdivi-1 
influences delivery of granules to surface connected membranes by cytoskeletal 
transport or docking at the release site. Following membrane fusion and initial 
pore formation, pore expansion can ensue, leading to full granule collapse and 
concomitant extrusion of granule contents. This process can be identified in 
amperometric spikes as a subtle increase in the current which is called a ‘foot’.  
Alternatively, the fusion pore can close after partial secretion in an event termed 
kiss-and-run exocytosis (Fig.3.7A). 
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Figure 3.6 Effect of compound E on rabbit platelet pore formation as measured 
by single cell amperometry. Compound E (10 µM), an mdivi-1 analog that lacks 
activity against Drp1, did not significantly affect quantal release (A), number of 
granule released per cell (B), time required for transition from fusion pore to full 
fusion (C), total time for release (D), % kiss and run events (E), or % foot processes 
(F). Data represent the average + S.E.M of 107 control tracings and 31 tracings from 
platelets exposed to compound E. 
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Figure 3.7 Role of Drp1 in stability of the platelet fusion pore.  
(A) During rabbit platelet granule exocytosis, a fusion pore forms as indicated by the 
foot process, shown as the initial inflection in the top amperometric tracing. This pore 
can then dilate rapidly, resulting in full granule collapse and complete release of 
granule contents as indicated by the spike (upper amperometric tracing). Alternatively, 
the fusion pore may reseal in a kiss-and-run event. This phenomenon typically results 
in a shallow inflection in the current tracing representing the release of a small amount 
of serotonin (lower amperometric tracing). (B) Cumulative frequency analysis in the 
presence and absence of 10 µM mdivi-1 demonstrated no difference in the rate of 
platelet dense granule release. Amperometric spikes were evaluated to determine (C) 
the percentage of kiss-and-run events and (D) the percent of spikes preceded by a 
foot process in the presence and absence of mdivi-1. These results demonstrate that 
mdivi-1 interferes with the expansion of the fusion pore to full fusion through a foot 
process, as indicated by the significant difference between the %foot values for mdivi-
1-treated and control platelets (p<0.01). Data represent the average + S.E.M. of 107 
control tracings and 39 tracings from platelets exposed to mdivi-1. 
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In this work, the spikes with an integrated area between 30 fC (approximately 
100 times the RMS noise of each tracings) and 100 fC (approximately 30% of the 
average Q value) are classified as kiss and run events.  Release events through 
fusion pores followed by either reclosure of the fusion pore or full release 
following foot process formation were monitored. The total %kiss-and-run events 
did not differ significantly between the two conditions (Fig. 3.7C). However, there 
was a significant difference between the fusion events completed by full fusion 
through a foot process in control platelets versus platelets exposed to mdivi-1 
(Fig. 3.7D) (% foot is 17.35+1.37 for control and 9.46+2.01 for mdivi-1 conditions, 
p<0.01). In contrast to the effects of mdivi-1, compound E had no effect on 
platelet pore formation (Fig. 3.6F). These results indicate that inhibition of Drp1 
impairs fusion pore stability. 
3.3.4 Drp1 Antagonism Inhibits Thrombus Formation 
Inhibition of Drp1 following infusion of mdivi-1 has previously been demonstrated 
to block reperfusion injury in cardiac, renal and retinal ischemia models.38-40 The 
protective effect has been attributed to prevention of mitochondrial fragmentation 
since Drp1 is known to function in mitochondrial fission.32, 41 However, antiplatelet 
compounds can also confer protection against reperfusion injury, and platelet 
function was not evaluated in previous studies.  
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Figure 3.8 Effect of mdivi-1 on platelet accumulation and fibrin generation 
during thrombu formation following laser injury of cremaster arterioles. 
Mouse platelet-specific anti-CD42b antibody conjugated to Dylight 649 (0.1 µg/g 
body weight) and fibrin-specific mouse anti-human fibrin II β-chain monoclonal 
antibody conjugated to Alexa 488 (0.5 µg/g body weight) were infused into the 
mouse. Mdivi-1 (50 mg/kg) was subsequently infused intravenously 5 minutes prior 
to the initial laser injury. Representative binarized images of the appearance of 
fluorescence signals associated with platelets (red) and fibrin (green) over 180 
seconds following laser-induced vessel wall injury in a wild type mouse are shown 
in panels (A) vehicle alone and (B) 50 mg/kg mdivi-1. (C) Median integrated 
platelet fluorescence intensity and (D) median integrated fibrin fluorescence 
intensity at the injury site are plotted versus time.  Data are from 28 thrombi in 3 
mice for control condition and 24 thrombi in 3 mice for mdivi-1 condition. 
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Since inhibition of Drp1 inhibits platelet exocytosis, we determined whether 
pharmacological inhibition of Drp1 on thrombus formation could control thrombus 
formation following vascular injury. Platelet accumulation (Fig. 3.8A, red) and 
fibrin formation (Fig. 3.8A, green) were monitored following laser-induced injury 
of cremaster arterioles prior to (Fig. 6A; supplementary video S1) and following 
infusion of mdivi-1 (Fig. 3.8B; supplementary video S2). A 59% reduction in 
platelet accumulation (p < 0.001, as determined by AUC) was observed following 
infusion of mdivi-1 (Fig. 3.8C). In contrast, there was no significant effect of 
mdivi-1 on fibrin generation following laser-induced vascular injury (Fig. 3.8D), 
consistent with other interventions specifically targeting platelet function in this 
model.42 
3.4 Discussion 
These experiments evaluate the role of Drp1 in platelet function using small 
molecules. The indication that Drp1 functions in granule exocytosis was originally 
derived from a chemical genetic screen of >300,000 compounds to identify 
inhibitors of platelet granule secretion. This unbiased forward screen identified a 
compound, ML160, which also demonstrated activity in an assay designed to 
identify inhibitors of the product of yeast Dnm1, the yeast ortholog of Drp1. 
Following the identification of ML160 as an inhibitor of platelet exocytosis, we 
used the two well-characterized dynamin family inhibitors, dynasore and 
MiTMAB, which also blocked platelet granule secretion (Fig. 3.3). This result 
implicates dynamin family proteins in platelet granule release. To evaluate the 
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role of Drp1 in granule release, we used the mdivi-1, which is selective for Drp1 
and has proven to be a useful compound in its study.35, 39, 40, 43, 44 Mdivi-1 inhibits 
exocytosis in the same concentration range that it inhibits the recombinant Drp1 
GTPase activity. The fact that the inhibitory activity of various mdivi-1 analogs in 
the exocytosis assay mirror their activity against the recombinant Drp1 GTPase 
(Fig. 3.4) further supports the premise that Drp1 is the relevant target of mdivi-1 
in the exocytosis assay.  
Studies demonstrating a role for Drp1 in granule secretion34, 36, 37 prompted us to 
evaluate the effect of mdivi-1 on serotonin release from individual granules using 
single-cell amperometry. Experiments were conducted with a low concentration 
of mdivi-1 (10 µM) so as not to impair total quantal release of serotonin [Q(fC)] 
and to enable direct comparison of tracings with untreated controls. Lower 
antagonist concentrations also decrease the likelihood of off-target effects. These 
studies demonstrated that mdivi-1 has a significant effect on spike width and the 
percent of foot processes associated with spikes (Figs. 3.5 and 3.7). Figure 3.5 
shows representative traces from both control and mdivi-1-exposed platelets. 
Unlike the control platelets, mdivi-1-treated platelets show an extended release 
behavior for each fused granule. This result implies that mdivi-1 impairs the rate 
of expansion of the fusion pore, and thus, slows the time course for serotonin 
release from individual granules. Moreover, foot process formation was inefficient 
when platelets were exposed to mdivi-1, demonstrating that inhibition of Drp1 
causes fusion pore instability. There are several potential mechanisms by which 
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Drp1 may control fusion pore dynamics. Drp1 colocalizes with mitochondria and 
δ-granule in platelets (Fig.3.2) and could participate in granule secretion via 
effects on mitochondria. In mast cells, either incubation with mdivi-1 or treatment 
with Drp1 siRNA blocks mitochondrial translocation required for activation-
induced TNF-α and β-hexaminidase release.34 Mitochondria play a prominent 
role in insulin secretion by generating required ATP and metabolites that 
stimulate secretory processes.45 Silencing Drp1 impairs insulin secretion in the 
hypothalamus.37 Mitochondria also contribute to synaptic vesicle release46 and 
Drp1 has been shown to function in this capacity.36 Mdivi-1 impairs mitochondrial 
permeability transition pore (MPTP) formation and reduces ischemia mediated 
death in cardiomyocytes.38 However, under the conditions of our assay, we found 
no effect of mdivi-1 on mitochondrial membrane potential(data not shown). 
Similarly, mdivi-1 had no effect on platelet apoptosis as measured by annexin V 
binding (data not shown). In contrast, antimycin A, an inhibitor of mitochondrial 
respiration, impaired mitochondrial membrane potential without blocking granule 
secretion.Thus, impairment of mitochondrial membrane potential is not a likely 
explanation for the effects of mdivi-1 on granule secretion.  An alternative 
possibility is that Drp1 acts to control fusion pore formation at the site of stalk 
formation. Unlike classical dynamins, Drp1 lacks a pleckstrin homology domain 
or SH3 domain and is not known to act at sites of membrane fusion. 
Nonetheless, Drp1 interacts with membranes and could potentially influence pore 
93 
 
expansion directly. Further studies will be required to determine the mechanism 
by which Drp1 controls platelet fusion pore dynamics. 
Inhibition of Drp1 blocked platelet accumulation during thrombus formation 
following vascular injury. In contrast, fibrin generation was unaffected (Fig. 3.8). 
This observation is consistent with the fact that fibrin generation following laser-
induced injury of the cremaster arteriole is independent of platelet 
accumulation.42 Infusion of mdivi-1 has previously been shown to decrease 
infarct size in murine ventricles in an in vivo model of cardiac ischemia-
reperfusion injury.38 Systemic infusion of 50 mg/kg of mdivi-1 has also been used 
to reverse ischemic renal injury and tubular apoptosis induced by reperfusion 
following renal ischemia.39 The effect was attributed to suppression of ischemia-
induced mitochondrial fragmentation. Similarly, mdivi-1 was shown to inhibit early 
neurodegenerative events and increase retinal ganglion cell survival following 
acute retinal ischemia.40 Our results using the same mdivi-1 concentration 
demonstrate that mdivi-1 is an antiplatelet agent in the setting of injury-induced 
thrombus formation. A limitation of our studies is that we cannot restrict the 
activity of mdivi-1 to platelets following systemic infusion. We cannot rule out an 
effect of mdivi-1 on endothelial cells in our assay. Nonetheless, since antiplatelet 
therapy can prevent tissue damage following reperfusion47-49 and mdivi-1 
interferes with platelet secretion, effects on platelet function must also be 
considered when assessing the role of Drp1 in reperfusion injury. The 
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combination of maintaining vascular patency and inhibiting apoptosis may be 
useful in the treatment of ischemic injury.  
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Chapter 4 
Exploring the Role of Phospholipids in Platelet Aggregation and 
Secretion 
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4.1 Introduction 
Since fusion between the granular membrane and the plasma membrane is a 
critical step of exocytosis, the characteristics and actions of lipid species is 
clearly of innate importance.1-3 Phospholipids constitute the majority of the lipids 
in both the plasma and granular membranes. Sphingolipids, including 
phosphotidylcholine (PC) and sphingomyelin (SM), are the most abundant, and 
they are localized primarily in the outer leaflet of the plasma membrane in resting 
cells. Aminophospholipids, including phosphatidylserine (PS) and 
phosphatidylethanolamine (PE), are the second most abundant phospholipids in 
the plasma membrane, and they are generally localized to the inner leaflet of the 
plasma membrane via an ATP-dependent aminotranslocase enzyme in resting 
cells.4-6 Activation of the cell deactivates aminotranslocase activity and activates 
Ca2+-dependent lipid scramblase, which results in exposure of PS to the outer 
leaflet, creating a more negatively charged cell surface. It has been shown that 
both the asymmetric distribution at rest and scrambling of the phospholipids upon 
activation are critical for the chemical messenger secretion process; in fact, 
disruption of the phospholipid asymmetry and redistribution impairs exocytosis.1, 
8-11 For example, in the case of Scott’s syndrome, where lipid scramblase activity 
is diminished, patients exhibit a hemostatic imbalance because PS cannot be 
exposed to the platelet surface properly.12 
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Platelets are dynamic secretory cells, essential for hemostasis and also involved 
in thrombosis and many other physiological processes.13 In platelets, 
phospholipids play particularly important roles in aggregation and secretion.4-6, 14, 
15 Phospholipids in the platelet membrane serve as binding sites for coagulation 
factors and also have catalytic activity in thrombotic reactions.  In resting 
platelets, the PC and SM in the outer leaflet of the plasma membrane minimize 
the binding of any coagulation factors. Upon vascular damage and platelet 
activation, PS is exposed to the platelet surface, which facilitates the binding of a 
variety of coagulation factors via ionic and stereoselective interactions.5 
Furthermore, phospholipids can amplify the blood coagulation process by several 
orders of magnitude. For example, PS accelerates the tenase and 
prothrombinase reactions by facilitating the binding of vitamin K-dependent 
coagulation factors and allowing conformational changes for maximum function 
of the coagulation proteins, leading to production of coagulation complexes.5 In 
addition to their procoagulant activity, phospholipids can also perform 
anticoagulation activity through feedback inhibition of thrombin formation.4, 5 
Although PS is often assumed to be the most important phospholipid species due 
to its strong interaction with coagulation factors, recent studies reveal that other 
phospholipids in the plasma membrane are also involved in blood coagulation. 
Moreover, there is evidence that membrane PS level and activity is regulated by 
other phospholipids, especially PE and PC.4  
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However, the exact role of membrane phospholipids in platelet activation and 
aggregation is not well characterized. 
In addition to aggregation behavior, asymmetric distribution of the phospholipids 
is also necessary for platelet secretion. Phospholipid content not only influences 
the fluidity and the curvature of the membrane but it also promotes shape change 
and spreading of the platelets during exocytosis. In fact, it has been shown that 
phospholipids can mediate both the mechanism and the kinetics of exocytotic 
events in PC 12 and chromaffin cells (model exocytotic systems).8-10, 16 However, 
there is little known about phospholipid regulation of platelet secretion.  
In this work, we examine the effect of membrane phospholipids on the major 
platelet functions of aggregation and exocytosis. To examine aggregation, 
platelets were incubated with different phospholipids in a microfluidic device and 
exposed to ADP, which is a strong platelet aggregation agonist that does not 
induce secretion. Microfluidic devices coated with endothelial cells were used in 
this work to mimic the vascular environment. 
Platelets have three different types of granules, and herein, we performed both 
ensemble and single cell analysis to elucidate the secretion from all three types. 
The bulk assays that were performed to assess the changes in the secretion 
behavior of platelets include HPLC detection of serotonin, a PF4 ELISA assay, 
and a β-hexoseaminadase assay to monitor platelet δ-granule, α-granule, and 
lysosome secretion, respectively. Moreover, single cell CFMA measurements 
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enabled evaluation of the phospholipid content effects on δ-granule quantal 
release and kinetics of the release. Results showed that, in fact, not only PS but 
all the other phospholipids considered influence both platelet aggregation and 
secretion. With the exception of PE, the phospholipids considered decreased 
platelet aggregation. Although PS incubation decreased the secretion of δ-, α-, 
and lysosomal granules, PE and SM enrichment increased secretion from 
platelet lysosomes. CFMA measurements showed that PC and PS regulate 
granule recruitment and influence the frequency of secretion events while PS 
enrichment improves the stability of the fusion event. Overall, this work 
demonstrates the involvement of membrane phospholipids in variety of platelet 
functions and highlights the importance of phospholipid-protein interactions in 
regulation of platelet behavior. 
4.2 Materials and Methods 
4.2.1 Platelet Isolation and Phospholipid Incubation 
Murine blood was drawn via cardiac puncture using 1 mL syringes pre-filled with 
200 µL ACD, and platelet-rich plasma was isolated using the procedure 
described previously. 17 Briefly, whole blood was centrifuged at 130xg for 10 min 
without brake, and the upper plasma layer was transferred to new tubes. 
Platelets were pelleted from the plasma by centrifugation at 500xg for 10 min and 
resuspended in fresh Tyrode’s buffer. 
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100 µM PS, PC, PE, and SM solutions were prepared by drying appropriate 
volumes of phospholipids as received in chloroform in glass vials with a stream of 
nitrogen and sonicating in Tyrode’s buffer for 2 hours, until all cloudiness had 
disappeared from the solutions. Phospholipid solutions were then filtered using 
0.2 µm filters. Platelets were incubated with phospholipid or negative control 
solutions for 2h. 
4.2.2 Relative Quantification of Phospholipid Enrichment 
Relative enrichments of PS, PC, PE, and SM in platelets were assessed using 
ultra-performance liquid chromatography coupled to tandem mass spectrometry 
(UPLC-MS/MS). Following incubation with PS, PC, PE, SM, or Tyrode’s buffer 
(control), platelets were washed twice by centrifugation at 1000xg and 
resuspended in 6:1 Tyrode’s buffer: ACD. After the final wash, platelets were 
resuspended in 100 µL Tyrode’s buffer. Plateles were mixed with 400 µL 
CHCl3/200 L MeOH/10 µL 19.1 µM PAF-d4 (internal standard) and sonicated for 
20 min. 100 µL 0.1% acetic acid in 0.1 M NaCl was then added and samples 
were sonicated for an additional 10 min. Samples were centrifuged for 5 min at 
1500 RCF, and the upper aqueous layer was removed and discarded. The lower 
organic layer was dried under vacuum, and phospholipids were resuspended in 
200 µL 0.1 % acetic acid in 40/60 A/B (A was 20 mM ammonium acetate in 
water, pH 5, and organic mobile phase; B was 9:1 ACN:acetone) by 1 hour 
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sonication. Samples were centrifuged at 1500 RCF for 5 min and transferred to 
fresh tubes prior to UPLC-MS/MS analysis.  
UPLC-MS/MS analysis was performed using a Waters Acquity Triple Quadrupole 
Mass Spectrometer using a modified version of the chromatography suggested 
by and a Waters BEH C8 2.1 x 100 mm column.18 Deuterated platelet-activating 
factor (PAF-d4) was used as an internal standard. Chromatography used 0.6 
mL/min initial: 40% A, 60% B held for 1 min; 2 min: 20% A, 80% B; 2.5 min: 16% 
A, 84% B held for 0.25 min; 3 min: 14% A, 86% B held for 0.25 min; 3.5 min: 
12.3% A, 87.7% B held for 0.25 min; 4 min: 5% A; 95% B held for 1 min; 5.5 min: 
40% A, 60% B held for 1.5 min. Electrospray ionization tandem mass 
spectrometry (ESI-MS/MS) was operated in positive ionization mode using the 
following parameters: capillary, 3.8 kV; extractor, 3.00 V; rf lens, 0.30 V; source 
temperature, 120 °C; desolvation temperature, 400 °C; cone gas flow, 20 L/hr; 
desolvation gas flow, 800 L/hr; collision gas flow, 0.2 mL/min; low-mass 
resolution (Q1), 12.00; high-mass resolution (Q1), 12.00; ion energy (Q1), 0.30;  
and varied collision energies listed in Table 4.1.  
Spike recoveries were assessed by adding 5 µM PS, PC, PE, and SM to control 
platelet samples. Lipid extraction was performed as described above. PS, PC, 
PE, and SM were quantified in each of control, phospholipid-incubated, and 
recovery sample using a calibration curve prepared exactly as the platelet 
samples were prepared. To account for variation in pelleting behavior of platelets 
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induced by phospholipid incubation, phospholipid quantification results were 
normalized to average protein values of control- or phospholipid-incubated non-
activated platelet pellets.  
4.2.3 Device Fabrication for Aggregation Measurements  
A microfluidic device, employed to monitor platelet aggregation behavior with 
varied phospholipid content, was fabricated as was previously described.7 Briefly, 
microfluidic channels were fabricated in polydimethylsiloxane (PDMS) using 
standard photo-/soft lithography techniques. The cell culture channel dimensions 
were 450 μm (width) x 100 μm (height) x 2500 μm (length). After the PDMS layer 
with channels was fabricated, inlet and outlet holes were punched using a 
syringe needle, and the PDMS layer was washed to remove any remaining 
PDMS debris blocking channels. Then, the PDMS layer was bound to a clean 
glass substrate via oxygen plasma treatment to close the channel. After 
completion of a device, a 70 wt% ethanol solution was injected through the 
channel followed by a sterilized water rinse for sterilization purposes. This step 
was repeated three times, and after drying the channel, the device was exposed 
to UV light in a bio-hood for 5 minutes and then kept in the bio-hood until use.  
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4.2.4 Endothelial Cell Culture and Coating of the Microfluidic Device 
Human endothelial cell line, Hy926, was purchased from American Type Culture 
Collection (ATCC, Manassas, VA). Dulbecco’s Modified Eagle Medium (DMEM) 
with high glucose (formula: 4mM L-glutamine, 4.5g/L L-glucose, and 1.5g/L 
sodium pyruvate (Gibco®, Carlsbad, CA)), supplemented with 10% fetal bovine 
serum and 1% penicillin and streptomycin (Sigma Aldrich, Milwaukee, WI) was 
used as the culture media and cells were cultured in a T-flask in an incubator 
with 5% CO2 at 37ºC. Cells were fed every other day and split once a week. 
Endothelial cells were used only in passages three through twelve.  
A day or two before the experiments, a microfluidic device was first incubated for 
30 minutes with a 250 µg/mL human fibronectin solution in an incubator. 
Meanwhile, trypsinized endothelial cells from a T-flask were washed and re-
suspended into the same culture media at a cell density of  ~107 cells/mL. The 
cell suspension was injected through the device inlet into the cell culture channel 
and kept in an incubator for 3 hours. The fresh cell culture media was then 
injected through the channel to remove any non-adherent endothelial cells 
remaining in the channel, and the device was maintained in an incubator, feeding 
the cells every 12 hours. A monolayer of endothelial cells was achieved within 48 
hours (80% of the devices), and devices that did not resulted in a complete, 
uniform monolayer of endothelial cells within 48 hours were discarded (20% of 
the devices).  
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4.2.5 Adhesion of Platelets Incubated with Phospholipids  
Devices with a uniform monolayer of endothelial cells were selected for 
experiments, and the channel was washed with fresh Tyrode’s buffer before 
exposure of endothelial cells to a stream of platelets. To facilitate visual 
distinction of platelets from endothelial cells, platelets were labeled with 
CMFDA19 (Invitrogen) dye prior to phospholipid incubation. After phospholipid 
incubation, platelets were activated with 5 µM ADP and introduced into the inlet. 
Flow control was accomplished using a syringe pump, and platelet suspensions 
were introduced onto the device through Teflon tubing. The endothelial cell-
coated chamber was exposed to a stream of platelets for 20 minutes at a 
constant flow rate of 30 µL/hr. This flow rate was chosen to minimize the shear 
stress generated by moving fluid and avoid mechanical platelet activation. After 
endothelial cell exposure to platelets, the cell culture channel was washed with 
fresh Tyrode’s buffer and fluorescence images were obtained on an inverted 
microscope (Nikon, Melville, NY) equipped with a CCD camera (QuantEM, 
Photometrics, Tucson, AZ) using Metamorph Ver. 7.7.5 imaging software. 
Platelets adhered to endothelial cells were counted, and for each experimental 
condition, five images (450μm x 500μm each) were averaged; in each case, five 
biological replicates were measured.  
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4.2.6 Bulk Platelet Secretion Measurements 
Platelet δ-granule secretion was measured after incubation of the PRP with 
phospholipids using HPLC as was previously described in Chapter 1. For α-
granule secretion, a PF4 ELISA assay was purchased from R&D systems and 
used as directed.  Lysosomal secretion was measured via a β-hexoseaminadase 
assay.20 Briefly, following incubation of platelets with phospholipid solutions, 
platelets were exposed to 10 U/mL thrombin solution or Tyrode’s buffer (as 
control). Platelets were spun at 500xg to pellet. Supernatant portions were used 
for the analysis of the secreted species (serotonin by HPLC, PF4 with ELISA 
assay, and secreted hexoaminidase with β-hexoseaminadase assay). Moreover, 
to determine the total amount of the analyte of interest found in each granule, an 
aliquot of the PRP samples for each condition was lysed prior to activation and 
analyzed. Thus, for each assay, the total analyte amount stored in platelets, 
secreted via thrombin activation, and released in unstimulated conditions were 
determined. A BCA protein assay was used for normalization of the results to 
prevent any differences in the data due to the differences in the platelet count. 
 
 
 
 
106 
 
4.2.7 Total Protein Quantitation 
Total protein in pelleted platelets was quantified with a Pierce Bicinchoninic acid 
(BCA) assay from Thermo Scientific, used as directed. Protein was extracted 
from platelet pellets with mammalian protein extraction reagent from Thermo 
Scientific, used as directed. 
4.2.8 CFMA Measurements 
Chapter 1 describes the fabrication of microelectrodes and the experimental 
setup for the CFMA experiments in detail.21 After incubation, a drop of the PRP 
was added to the experimental chamber filled with Tyrode’s buffer supplemented 
with the phospholipid of interest. An individual platelet was activated by 10 U/mL 
of thrombin solution. Current versus time data were collected for 90 s. Since the 
completion of CFMA measurements with all the phospholipid conditions on the 
same day was not possible, each phospholipid condition was compared with its 
own control measured from the same platelet sample on the same day.  Data 
were analyzed as was previously described. The numbers of individual platelets 
analyzed per phospholipid condition were: (control =20, PC= 21); (control= 47, 
PE= 27); (control=20, PS=18); and (control=58, SM=45).  
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4.3 Results 
4.3.1 Relative Quantitation of Phospholipids 
Quantification of lipid species is quite challenging. Herein, relative phospholipid 
enrichment of platelet membranes was assessed using a UPLC-MS/MS method. 
Mobile phase composition and column selection were based on a previously 
published work reported by Rainville and Plumb,18 and chromatography was 
modified from the same report to a 7 min separation by adjusting the 
chromatographic conditions to the conditions for elution for each compound. An 
absolute quantification method was not possible because the phospholipid 
standards contained mixtures of fatty acid tails with a common headgroup. 
Instead, fragmentation transitions for the primary component of each 
phospholipid were monitored, and lipids extracted from phospholipid-incubated 
platelets were compared to those extracted from control platelets. Phospholipid 
concentration values were then normalized to extracted protein values from 
platelet pellets incubated with phospholipids and washed under the same 
conditions as the platelets from which the phospholipids were extracted. The 
transitions that were used for the assessment of the enrichment for each 
phospholipid are given in Table 4.1. All phospholipid transitions were monitored 
in all platelet samples, and enrichment was only observed in the phospholipid in 
which the platelets had been incubated. Thus, 2h incubation was enough time for 
platelets to take up the phospholipid that they were incubated in without up/down 
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regulating the other endogenous phospholipids.  This allowed us to directly 
compare the effect of enrichment of each particular phospholipid on the platelet 
secretion and aggregation behavior. The percent increase in phospholipid 
content was 58.14 ± 36.01, 59.89 ± 10.93, 325.6 ± 47.24, 193.3 ± 50.97 for PS, 
PC, PE and SM conditions, respectively. Surprisingly, the % enrichment for PE 
and SM conditions were drastically higher than the PC and PS conditions. For 
PE, this is perhaps due to the very small quantities of the PE species monitored 
in the control samples. 
4.3.2 Phospholipids and Platelet Aggregation 
While all other experiments used thrombin activation, the microfluidic adhesion 
experiment used ADP activation to specifically investigate adhesion of platelets  
because ADP is known to induce platelet adhesion but not secretion.22 Although 
the adhesion of ADP-activated platelets from each condition was relatively 
consistent, the number of platelets adhered to endothelial cells varied from day to 
day, and thus, comparisons of platelet adhesion to endothelial cells under each 
phospholipid condition were done with respect to the number of control platelets 
adhered to endothelial cells.  
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The ratios measured for each condition were tested to see if they were 
statistically different from 1 because a ratio of 1 indicates the same number of 
adhered platelet in the control and phospholipid-enriched platelets. As seen in 
the Figure 5.2, platelets incubated with PC, PS, and SM showed reduced 
adherence to endothelial cells compared to the control condition, with ratios of 
0.311±0.036, 0.625±0.075, and 0.516±0.125 for PC, PS, and SM, respectively. In 
contrast, platelets incubated with PE adhered to the endothelial layer in 
significantly higher numbers, with a ratio of 1.553±0.022 (p values are 0.0001, 
0.037, 0.0004, 0.0023 for PC, PE, PS, and SM, respectively).  
4.3.3 Assessment of α-granule, δ-granule, and Lysosomal Release at 
Altered Phospholipid Levels with Bulk Secretion Assays 
Since a method that enables measurement of α-granule and lysosome release 
with sub-ms time resolution at single platelet level is not available, bulk secretion 
assays were performed under conditions with phospholipid enrichment. The bulk 
δ-granule secretion will be compared with single cell data (vida infra). In all 
cases, the amount of secreted molecules from each type of granule was 
normalized according to platelet protein content. 
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Table 4.1 Summary of the UPLC-MS/MS analysis of each phospholipid 
 
 
 
 
 
 
Phospholipid Incubation 
Condition 
 
 
Control 
 
PS 
 
PC 
 
PE 
 
SM 
 
Transition used for 
relative 
quantitation 
 
 
n/a 
 
812.5627.4 
 
782.986.1 
 
718.3577.3 
 
703.8184.1 
Instrumental Precision 
(RSD) 
 
n/a 9.312 15.94 15.93 7.635 
Biological Precision 
(RSD) 
 
n/a 17.46 17.58 13.31 23.59 
Recovery (% ± SD) at 5 
µM 
 
n/a 83.06 ± 6.474 107.3 ±6.374 85.39 ± 13.26 64.75 ± 5.559 
Total protein in pelleted 
platelets (µg/mL ± 
SD) 
 
53.55 ± 5.00 44.26 ± 4.98 40.65 ± 4.99 37.48 ± 5.34 44.89 ± 5.60 
Percent increase in 
platelets upon 
incubation (range 
in 4 replicates) 
 
n/a  
12.57 – 100.5 
 
51.56 –75.99 
 
288.5 – 392.9 
 
145.7 – 245.9 
Average percent 
increase  
(Percent ± SD) 
 
n/a 58.14 ± 36.01 59.89 ± 10.93 325.6 ± 47.24 193.3 ± 50.97 
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Figure 4.1 Platelet aggregation measurements.  
(A) Design of the microfluidic device used for the measurements. (B) Ratio of the 
platelet numbers adhered at each condition to control. (p values are 0.0001, 0.037, 
0.0004, 0.0023 for PC, PE, PS, and SM respectively *denotes p<0.05, ** denotes p< 
0.01, *** denotes p<0.001).7 
 
 
A B
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Bulk assay results show that an increase in the PS content impaired both α- and 
δ- granule secretion. While platelets not treated with any phospholipid secreted 
0.0281±0.0017 µg serotonin/µg protein, PS  incubation led to a decrease in the 
average amount of serotonin secreted to 0.0093±0.0019 µg serotonin/µg protein 
(Figure 4.2D; p=0.002). A more drastic effect was observed in α-granule 
secretion; upon PS enrichment, PF4 secretion was almost completely 
attenuated, showing similar PF4 values with the unactivated platelets (Figure 
4.2B). PS also impaired lysosomal secretion. However, unlike α-and δ- granular 
release, lysosomal secretion increased with enriched PE and SM levels 
compared to control (p=0.0003 for PE, p<0.0001 for SM).  This shows that PE 
and SM facilitate lysosomal release and may indicate that PE and SM interact 
with proteins that promote lysosomal secretion, including cytoskeletal proteins or 
membrane proteins that help anchor the lysosomal membrane with the plasma 
membrane. In previous work, an increased lysosomal activity upon SM 
accumulation was reported through SM binding to the LAMP 1 on lysosomes in 
stress-resistant cells.23 
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Figure 4.2 Assessment of phospholipid effect on platelet granule secretion. 
(A) A representative figure illustrating three different platelet granule types; δ-granule, 
bull eye shape; lysosome, pink shape; and α-granule, uniformly filled irregular shapes. 
Phospholipids are asymmetrically distributed. (B) PF4 release from α-granules after 
different phospholipid enrichment. (C) Lysosomal release increased with PE and SM 
enrichment and decreased with PS uptake. (D) δ-granule secretion was also 
suppressed at high PS concentrations. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
compared to control. 
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4.3.4 Effect of Phospholipids on Platelet δ-Granule Secretion 
The time resolution of the CFMA technique enables a more detailed 
characterization of the δ-granule secretion and reveals the biophysical 
mechanistic underpinnings of the bulk measurements 21 
PC did not affect the quantity of the serotonin released from platelet granules or 
the kinetics of the release events(Figure 4.3A). However, the number of δ-
granules released per secretion event was significantly lower for PC-enriched 
platelets (N= 7.20±0.63 for control; N= 5.36±0.55 for PC condition p= 0.0337). 
Moreover the cumulative frequency of the release analysis showed that in early 
stages of secretion, the control and PC-treated platelets release granules with 
similar frequency, but that PC-enriched platelets slow granule release frequency 
before control platelets. This implies that the PC may influence the granular 
recruitment which will be discussed later in detail.  
Although incubation of the platelets with PE and SM resulted in great enrichment 
of these phospholipids, neither of these platelet pools showed a significant 
change in the platelet δ-granule secretion (Figure 4.4 and 4.5). It should be noted 
that PE incubation gave rise to the highest number of events with a foot feature; 
however this effect was not significant compared to control condition (p=0.075). 
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Figure 4.3 Effect of PC on δ-granule quantal release and release kinetics. 
(A) PC did not influence the amount of serotonin released from single granules. 
Kinetics of the release (B) and (C) were also unchanged. (D) A lower number of 
granules exocytosed from single platelets with comparable fusion pore stability (E). 
(F) Cumulative frequency analysis shows initially fast but later slowed granule 
trafficking in PC-enriched platelets.*p=0.05. 
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Figure 4.4 Effect of PE on δ-granule quantal release and release kinetics. 
(A) PE did not influence the amount of serotonin released from single granule. 
Kinetics of the release (B) and (C) were also unchanged. (D) Similar number of 
granules were exocytosed from individual platelets with comparable fusion pore 
stability (E). Cumulative frequencies of the release are the same for each condition 
(F). 
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Figure 4.5 Effect of SM on δ-granule quantal release and release kinetics. 
(A) SM  did not change the amount of serotonin released from single granule, (B) 
and (C) kinetics of the release; (D) number of granules exocytosed from single 
platelet; (E) fusion pore stability or (F) cumulative frequency of the release. p>0.05 
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Figure 4.6 Effect of PS on δ-granule quantal release and release kinetics. 
(A) PS did not influence the amount of serotonin released from single granules. 
Similar Trise (B) but higher T1/2 (C) values obtained. (D) Number of granules 
exocytosed from single platelets did not change.(E) PS increased fusion pore 
stability. (F) Cumulative frequency analysis shows initially fast but later slowed 
granule trafficking in PS-enriched platelets.*p=0.05. 
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PS was the phospholipid that altered the platelet δ-granule secretion the most. 
Upon PS enrichment, the platelet’s quantal secretion did not change (Q= 
262.70±36.06; 317.50±29.10 fC for control and PS conditions, respectively; 
p=0.246). Since the average number of granules secreted from individual 
platelets did not change between the conditions, it can be concluded that the 
total amount of serotonin secretion does not change with PS enrichment. This 
contradicts with bulk serotonin secretion measurement in which PS lowered the 
amount of serotonin extruded. Since single cell measurements are performed by 
measuring the action of one cell at a time in a relatively isolated space, it is 
unlikely that the activated secretion of one platelet will have a downstream effect 
of activation on another one. In bulk measurement, however, this interaction is 
unavoidable; initially activated platelets will secrete chemical messengers that 
will activate the platelets that were not initially activated. The discrepancy 
between the single cell and ensemble measurement is likely the impairment of 
the downstream effect. However, without single cell measurements it is not 
possible to observe the actual response to the stimulation, nor the heterogeneity 
in the response changing from platelet to platelet. 
Although a similar amount of serotonin is extruded from platelet granules in both 
control and PS-enriched conditions, the secretion kinetics slow at higher 
membrane PS concentrations (T1/2 values are 12.39±3.01 and 21.67±2.38 ms for 
control and PS conditions, respectively; p=0.0048). Although the number of 
granules secreted from individual platelets (N numbers) did not change, similar to 
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PC-treated platelets, the platelets enriched with PS also showed two different 
phases in terms of frequency of exocytosis (Figure 4.6F). In the early phase, the 
granules that were docked before activation were released with a comparable 
frequency to the control condition. However, the frequency of the granular 
secretion decreases, showing slower granule trafficking and docking compared 
to the control condition. Finally, fusion pore analysis showed that PS enrichment 
increased the stability of the fusion pore, with foot events occurring in 23.6±4.6% 
of the total secretion events, compared to 12.4±3.0% foot events observed for 
control. 
4.4 Discussion  
Phospholipids are the major components of the plasma and granule membrane, 
and in addition to their structural importance as a cellular barrier that separates 
the intracellular and extracellular environment, they are also dynamically involved 
in and regulate many cellular processes. In platelets, the phospholipid 
components are especially critical because it is likely that phospholipids are 
involved in platelet aggregation and secretion. However, there is not much known 
about how the different lipids regulate platelet behavior. In this work, the most 
common membrane phospholipids (PC, PS, PE and SM) were used to study the 
effect of phospholipid enrichment on both platelet aggregation (using a 
microfluidic device to mimic the vascular environment) and granular secretion 
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(using CFMA and bulk secretion assays to evaluate the importance of 
phospholipids in platelet α- and δ- granule and lysosomal release).  
Platelets were incubated with each of the phospholipids for 2h, long enough to 
enrich the platelets with the phospholipid of interest but short enough to minimize 
the up or down regulation of the synthesis of other phospholipids. MS analysis 
confirmed that only the phospholipid content that the platelets were incubated in 
changed, without any significant change in the composition of other 
phospholipids. This allowed an unambiguous evaluation of the effect of each 
phospholipid in platelet function. 
Use of microfluidic devices coated with endothelial cells simulated blood vessels 
for evaluation of platelet aggregation. To separate platelet aggregation from 
secretion we used ADP, a strong agonist for platelet aggregation but not 
secretion.22 5 µM ADP provided a moderate platelet activation and the ability to 
count the number of stained, adherent platelets for each condition. Although PS 
is mostly known for its procoagulant function, PS enrichment in fact diminished 
the platelet aggregation compared to control platelets. Besides providing a 
negatively charged surface to facilitate the binding of the coagulant factors, 
flipping of PS from inner leaflet of the plasma membrane to the outer leaflet 
provides reorganization of the coagulation proteins in the plasma membrane. 
Upon PS incubation, it is likely that the PS concentration on the outer leaflet of 
the platelet membrane increased and impaired the translocation of the PS from 
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inner leaflet to outer leaflet, thus diminishing the reorganization of the coagulation 
proteins that would facilitate platelet adhesion to endothelial cells. This 
observation is in agreement with the previous findings in which the higher plasma 
level of PS-decreased platelet coagulation and thrombus formation.4, 14 On the 
other hand, this is the first report, to the best of our knowledge, that the 
anticoagulant effect of PC and SM has been shown. In resting platelets, PC and 
SM reside mostly on the platelet surface and prevent platelet activation by 
providing a mostly neutrally charged membrane. The enrichment of these two 
phospholipids may prevent platelet aggregation in the same manner. Unlike 
these three phospholipids, PE boosted platelet aggregation by causing 50% 
more platelet aggregation than control platelets. Previous work published by 
Zieseniss et al showed that oxidized PE is one of the major components of low 
density lipoproteins that cause very strong thrombotic function.24 A similar effect 
explains our observations and reveals that PE synthesis and oxidation may be a 
good target for thrombosis prevention. 
In addition to their role in platelet aggregation, phospholipids are major 
components of exocytosis. During exocytosis, phospholipids not only serve as a 
matrix and accommodate essential proteins for membrane fusion but, by 
controlling the fluidity and curvature of the membrane, they influence the energy 
required for each step of exocytosis, especially the formation and stability of the 
fusion pore.16, 25-28 We first performed bulk secretion measurements on the all 
types of platelet granules. Both α- and δ- granule secretion diminished greatly 
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upon PS enrichment. None of PE, SM or PC enrichment changed the bulk 
exocytosis characteristics of these two granule populations. Surprisingly, 
lysosomal release was enhanced upon both PE and SM enrichment. It is known 
that phospholipids interact with the exocytotic machinery; moreover, it is shown 
that there are specific sub-units of proteins involved in recruitment and secretion 
of specific types of platelet granules. A similar scenario may be true for 
lysosomal release where specific interactions of PE and SM are required. 
Although SM regulation of lysosomal function has been reported in other cell 
types23 there is not any precedent work on platelets; thus, future work will explore 
these data further.  
Amperometric recordings of δ-granule secretion enabled detailed evaluation of 
the secretion at altered phospholipid levels. Neither PE nor SM caused any 
change in the quantal release or the secretion kinetics. However, PS enrichment 
resulted in longer secretion events with a prolonged spike width (higher T1/2) 
(Figure 4.6C). Although PC treatment did not influence the amount of serotonin 
released per granule or the kinetics of release, significantly lower numbers of 
granules were released from the platelets enriched with PC (p=0.033). Moreover, 
cumulative frequency analysis of the release showed that upon activation, both 
control and PC-treated platelets release their granules around the same pace but 
that PC-treated cells lag later in the secretion event. In early moments of the 
exocytosis, the granules that are released immediately constitute the already 
docked granules. Release of the other granules requires recruitment of the 
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granules to the site of fusion and docking. Both low N numbers and slower 
release frequency indicate the possible effect of PC on granule recruitment and 
docking. A possible effect of PC on vesicle requirement in PC12 cells has been 
reported previously.8 Moreover, recent work has demonstrated that PC enriched 
in axons of neurons shows a proximal to distal gradient which is regulated by 
actin dynamics. This type of inter-regulation may be possible between platelet 
PC and cytoskeleton where the disruption in PC localization interferes with actin 
function and recruitment to the membrane. 29 Although this would reveal a unique 
regulatory pathway for platelet granular release, further work needs to be done to 
test this hypothesis. A more apparent two phase frequency of release was also 
observed with PS-enriched platelets, although the N numbers were not different. 
This implies a regulatory effect of PS on granular recruitment but not docking.  
Although PE and SM support negative membrane curvature, PS packs better on 
positively curved membranes. PC forms almost a flat layer, with minimal 
influence on membrane curvature. The role of phospholipid curvature in 
exocytosis becomes more prominent during fusion pore formation. 16, 25-28 Fusion 
pores are highly curved membrane structures that require phospholipids with 
positive curvature to pack in the outer leaflet and the phospholipids with negative 
curvature to pack on the inner leaflet for stabilization. To achieve a stable fusion 
pore, the phospholipid with appropriate curvature should be on the appropriate 
side of the membrane. As expected, the % of fusion events with a foot (stable 
fusion pore) did not change with PC enrichment. Although both PE and SM 
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incubations slightly increased the % of foot events, the changes were not 
significant (p=0.075 for PE and 0.353 for SM). While it is known that the lipids 
with negative curvature stabilize the fusion pore better, PS (with positive 
curvature) provided more stable fusion pores compared to untreated platelets. 
This can be attributed to the exposed PS on the surface of the membrane upon 
activation which stabilizes the positive curvature of the fusion pore. Previous 
work reported the time of PS transport from inner leaflet to outer leaflet of the 
membrane as 3 min.4 During 90 s of amperometric recordings, it is likely that 
more than half of the PS was exposed to the plasma outer surface. Moreover, 
PS-enriched PC12 cells also displayed more stable fusion pore events which 
was attributed to the interaction of PS with synaptotagmin that gave rise to highly 
bended membrane with negative curvature. 16, 25-28, 30 Platelets have 
synaptotagmin-like protein 1 and its interaction with PS is not known.31 
Herein, we have demonstrated how different phospholipids can act on different 
aspects of platelet function. We demonstrated that although PE does not affect 
platelet α- and δ-granule secretion, it over activates the thrombotic function of 
platelets. Moreover, this work highlights the possible interaction of phospholipids 
with important proteins involved in the secretion process. Elucidating the function 
of lipid-protein interactions will improve our current understanding of platelet 
secretion since it is obvious that the platelet secretion is regulated synergistically 
by both protein and lipid species.  
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Chapter 5 
Cholesterol Effects on Granule Pools in Chromaffin Cells Revealed by 
Carbon-Fiber Microelectrode Amperometry 
 
 
 
 
 
 
 
 
 
 
Adapted from: 
Koseoglu S, Love SA, Haynes CL. Cholesterol effects on vesicle pools in 
chromaffin cells revealed by carbon-fiber microelectrode amperometry. Anal 
Bioanal Chem. 2011;400:2963-2971 
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5.1 Introduction 
Upon stimulation, many cells release chemical messenger molecules through the 
tightly regulated process of exocytosis. Understanding the underpinnings and 
driving forces of this highly conserved process is critical from both a fundamental 
and applied perspective. Since exocytosis involves coalescence of the cellular 
and granular membranes to form a fusion pore that then dilates to release 
granular content, components of the membrane are likely critical in how, and if, 
this process proceeds. The cellular plasma membrane has two important 
components that may influence the fidelity of exocytosis: proteins and lipids. 
Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) 
membrane proteins have been studied extensively and are known for their role in 
membrane mixing.1-4 Knowledge about the effect of membrane lipids on 
exocytosis, however, is limited.5, 6 Cholesterol is one of the major lipids found in 
the membrane, with numerous structural and functional capacities. Cholesterol 
lends structure to the membrane, facilitating the formation of cholesterol-rich 
microdomains that are sometimes called lipid rafts.4, 7 It has been shown that 
these lipid rafts are important regulators of SNARE function. 3, 4, 8  For example, 
syntaxin (a SNARE protein) embedded in cholesterol-rich rafts has been shown 
to be the preferential site for exocytosis. In addition, depletion of membrane 
cholesterol disrupts these domains and decreases the number of exocytotic 
events in PC12 cells, an immortal chromaffin cell line often used to model 
exocytotic processes.3 Although the direct effects of lipid modulation on 
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exocytosis have not been explored, the localization of other SNARE proteins, 
including SNAP25 and SNAP23, in these cholesterol-rich domains has been 
reported.4 Furthermore, cholesterol may influence the energetics of fusion pore 
formation, stability of the fusion pore, and the overall energy dissipation based on 
the fluidity and the curvature of the membrane7, 9-12  
Clearly, a better understanding of the role of cholesterol in exocytosis is 
necessary. Choice of a model cell is particularly critical when studying 
fundamental aspects of exocytosis. Chromaffin cells are neuroendocrine cells 
found in the adrenal gland, and they store and release catecholamines. Besides 
their importance in the physiological fight-or-flight response, they have been 
widely used as model cells for neuron secretion based on common progenitor 
cells.9, 13, 14 Careful study of these granules using total internal reflection 
fluorescence microscopy with fluorescent timer proteins, capacitance, and 
amperometry measurements has demonstrated that chromaffin cell granules are 
spatially distributed according to their age and that they have varied capacity for 
exocytosis.15, 16  Newly assembled granules (about 140 granules in mouse 
chromaffin cells) constitute the readily releasable pool (RRP); this pool is already 
primed and docked at the plasma membrane and releases instantaneously upon 
chromaffin cell activation. The slowly releasable pool (SRP) is an intermediate 
pool that is in dynamic equilibrium with the RRP, showing a delayed release 
response compared with the readily releasable pool. The oldest granules (an 
average of 4,000 in mouse chromaffin cells) make up the reserve pool (RP), 
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granules localized in the interior of the cell, requiring transport to the plasma 
membrane before exocytosis.15-17   
Both spectroscopic and electrochemical analyses reveal that these pools can be 
selectively activated with different secretagogues.18-20 Nicotine and K+ 
stimulations preferentially activate the younger granules (mainly the RRP) 
whereas Ba2+ selectively activates the older (mainly RP) granules. Although it 
has recently been demonstrated that membrane cholesterol content influences 
the release behavior of the RRP granules in chromaffin cells, 9, 10 there is no 
information about how or whether the release of older granules changes with the 
cellular cholesterol content. Moreover, the effect of membrane cholesterol on 
subsequent release events has not been explored. In this work, we 
systematically vary the membrane cholesterol content in primary culture 
chromaffin cells to study the effect of membrane cholesterol on release of 
different granule pools and the recovery of release in chromaffin cell granules. 
Our results show that, although cellular cholesterol level influenced the stability of 
fusion pore, it did not change the quantity or the kinetics of the younger granule 
release, due to the low occurrence of the events with a sustained fusion pore 
compared with the full fusion events. Moreover, cellular cholesterol content 
caused quantal and kinetic changes in the subsequent release events when cells 
were stimulated a second time. Finally, preferential release of the oldest granules 
upon Ba2+ stimulation showed different behavior than that of the younger granule 
pools, suggesting that these granule pools are biochemically and/or 
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morphologically distinct or that they are released from different sites of the 
plasma membrane. 
5.2 Materials and Methods 
5.2.1 Cell isolation and culture 
For amperometry experiments, primary culture murine adrenal medullary 
chromaffin cells were isolated from wild-type brown mice (C57BL/6J, Jackson 
Laboratories) according to an approved University of Minnesota Institutional 
Animal Care and Use Committee protocol (#0807A40164). For cholesterol assay 
experiments, mice from the University of Minnesota tissue-sharing program were 
used for cell isolation due to the large number of cells required. A previously 
published procedure was used for cell isolation from mice.21 Briefly, mice were 
euthanized, and the adrenal glands were excised from above/ adjacent to the 
kidneys and kept in ice-cold Dulbecco’s modified eagle medium (DMEM) with 
Ham’s nutrient 12 mix (DMEM/F12 1:1, Invitrogen, Carlsbad, CA) media until 
they were dissected on a PDMS board in chilled Locke’s buffer (154 mM sodium 
chloride, 3.6 mM potassium chloride, 5.6 mM sodium bicarbonate, 5.6 mM 
glucose, and 10 mM HEPES in water sterile filtered and pH adjusted to 7.2; 
Sigma-Aldrich, St. Louis, MO) to remove cortical tissue. Removal of the 
medullary tissue was accomplished by digestion in neutral protease (Worthington 
Enzyme, Lakewood, NJ) with an activity of 25 U/mL followed by repeated 
washing and triteration in DMEM/ F12 media. Cell suspension was cultured in 
35-mm Petri dishes (for carbon-fiber microelectrode amperometry (CFMA) 
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experiments) or multi-well plates (for cholesterol assays), incubated at 37 °C in a 
5% CO2 atmosphere and used within 48 h of cell harvest. 
 5.2.2 Manipulation and Measurement of Cellular Cholesterol Methyl-β- 
Cyclodextrin 
 (MBCD) is a well-known cholesterol carrier, and it can act as either a cholesterol 
acceptor or donor depending on the cholesterol/MBCD ratio.22 In this work, both 
MBCD and cholesterol-saturated MBCD solutions were freshly prepared by 
dissolving MBCD/ cholesterol-saturated MBCD in DMEM/F12 and sonicating for 
30 min, followed by pH adjustment to 7.3 and filtration. Cellular cholesterol was 
depleted upon incubation of the cells in 10 mM MBCD in DMEM/F12 media for 
30 min. 
Replenishment of the depleted cholesterol was achieved by an additional 30 min 
incubation of cells in 5 mM cholesterol-saturated MBCD in DMEM/F12 after 
depletion as described above. Cholesterol quantification was done using the 
Amplex red cholesterol assay kit (Invitrogen, Carlsbad, CA), and the amount of 
cholesterol was reported as nanograms cholesterol/microgram protein, where 
protein content was determined using a standard protein assay kit (Thermo 
Fisher Scientific, Waltham, MA). Briefly, followed by incubation, cells were 
washed with PBS buffer and lysed with M-PER protein extraction reagent. Then 
0.1 mL of cell suspension was mixed with Pierce 660 Protein assay solution, and 
the absorbance at 660 nm was measured after 5 min of incubation. For 
quantitation of protein, a calibration curve was built by measuring the absorbance 
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of standard bovine serum albumin solutions with concentrations from 125 to1,500 
μg/ml. For cholesterol analysis, 50 μl of cell suspension was added to a mixture 
of Amplex red reagent (300 μM), horseradish peroxidase (2 U/mL), and 
cholesterol oxidase (2 U/mL) in reaction buffer. After incubation for 1 h at 37 ºC, 
fluorescence measurements were done by microplate reader. The calibration 
curve for cholesterol analysis was also generated by using prepared cholesterol 
solutions with known concentrations of 2 to 20 μM. To obtain measurable 
cholesterol levels, for the cholesterol assay experiments, cells were obtained 
from 10–12 mice.  
5.2.3 Microelectrode preparation and amperometry experiments  
Carbon-fiber microelectrodes were fabricated according to a previously published 
procedure.14 A carbon fiber (Thornel T650, Amoco Corp., Greenville, SC) was 
aspirated into a glass capillary, and the glass layer was tapered around the fiber 
using a resistively heated micropipette puller (PE-21, Narishige, Tokyo, Japan). 
The carbon fiber was trimmed with a scalpel to get an exposed length of less 
than 20 μm. Insulation was achieved by dipping the electrodes into preheated 
mixture of EPON resin 828 (Miller-Stephenson, Morton Grove, IL) with 15 % wt. 
1,3-phenylenediamine hardener (Sigma-Aldrich, St. Louis, MO). Electrodes were 
allowed to cure at room temperature for 24 h followed by further curing at 100 °C 
for 12 h and at 150 °C for 12 h. Prior to amperometry experiments, electrodes 
were polished to a 45° angle using a diamond-embedded beveling wheel (Sutter 
Instrument Company, Novato, CA) and stored in isopropyl alcohol purified with 
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activated carbon until use. For electrical conductance, electrodes were backfilled 
with 4.0 M potassium acetate and 150.0 mM potassium chloride solution. 
Amperometry experiments were performed with an Axopatch 200B potentiostat 
(Molecular Devices, Inc., Sunnyvale, CA) using low-pass Bessel filtering (5 kHz), 
a sampling rate 20 kHz, and gain amplification of 20 mV/pA, all controlled by 
locally written LabVIEW software and National Instruments data acquisition 
boards. Cells were visually monitored during experiments with an inverted 
microscope equipped with phase contrast optics (Nikon Instruments, Melville, 
NY). To keep the cells at constant physiological temperature (37 °C), Petri dishes 
were kept in a temperature-controlled chamber (Warner Instruments, Hamden, 
CT). A two-electrode configuration was used, and the catecholamines, 
epinephrine, and norepinephrine were oxidized at +700 mV vs a Ag/AgCl 
reference electrode (BASi, West Lafayette, IN). To introduce chemical stimulation 
to the cell of interest, fire-polished glass capillaries were used with an average 
tapered diameter of 10 μm. Delivery of the secretagouge was provided by 
applying nitrogen pressure to the stimulant-filled capillary using a PicoSpritzer III 
(Parker Hannafin, Cleveland, OH). 
Burleigh PCS500 piezoelectric micromanipulators (EXFO, Mississauga, Canada) 
were used to position both electrode and stimulating pipette on or near individual 
cells. The carbon-fiber microelectrode was positioned in contact with the cell of 
interest while the stimulating pipette was placed approximately 50 μm away from 
the cell in the same z plane. Potassium stimulation experiments were done in 
134 
 
buffer containing 150 mM NaCl, 12.5 mM Tris, 4.2 mM KCl, 5.6 mM glucose, 1.5 
mM CaCl2, and 1.4 mM MgCl2. Potassium stimulation solution was prepared from 
60 mM KCl, 94.2 mM NaCl, 12.5 mM Tris, 5.6 mM glucose, 1.5 mM CaCl2, and 
1.4 mM MgCl2. Neither the buffer nor the stimulating solution contained Ca
2+ for 
barium experiments. The buffer for barium stimulation experiments contained 
150 mM NaCl, 5 mM KCl, 10 mM HEPES, 1.2 mM MgCl2, and 5 mM glucose. 
The stimulation solution of 5 mM Ba2+ was prepared by adjusting the 
concentration of NaCl to obtain a buffer and stimulating solution with matching 
osmolarity. All the solutions were sterile filtered and pH-adjusted to 7.4. For the 
control condition, cells were washed twice with buffer solution and placed into the 
temperature-controlled chamber for electrochemistry experiments. For the 
condition which will be referred to as MBCD in the remainder of this paper, cells 
were exposed to 10 mM MBCD containing DMEM/F12 media for 30 min and then 
washed with buffer solution, and amperometry experiments were performed. The 
reload condition includes both the depletion of membrane cholesterol as it was 
described in the MBCD condition and a replenishment step with 30 min 
incubation of cells in 5 mM cholesterol-saturated MBCD in DMEM/F12. All the 
amperometry measurements were done within 2 h after the cells were removed 
from DMEM/F12 media. For K+ single stimulation and Ba2+ stimulation 
experiments, cells were triggered 3 s after electrochemical recordings began. For 
double stimulation experiments, cells were triggered at 3 and 33 s after 
electrochemical recordings began. 
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For single stimulation data analysis, Q, Trise, Tdecay, T1/2, and foot% were used 
to determine how changes in membrane cholesterol influence the course of 
exocytosis (see Chapter 2 for details). The aim of the double stimulation 
experiments was to see whether membrane cholesterol content would influence 
the granule recycling and recovery of the cell after the first release event. For this 
reason, in addition to comparing each parameter to the control, ratios of these 
parameters (i.e., Q1/Q2, (Trise)1/ (Trise)2, etc.) were also considered to get a better 
understanding of cell recovery between the first and second stimulation. In 
addition, cumulative frequency analysis enabled visualization of granule release 
over time for each condition.  
5.3 Results and Discussion 
5.3.1 Cholesterol Analysis 
Cellular cholesterol content after each treatment was determined using well-
known cholesterol and protein assays. The results are reported as cholesterol 
percentage compared with control. Methyl-β-cyclodextrin treatment reduced the 
cholesterol level to 55.1±3.5% of control. Although the reload condition gave an 
average cholesterol concentration of 134.1±27.2% of the control, there is a wide 
% range from 102–188% obtained from various replicates (data not shown). 
Although MBCD is sufficiently selective for cholesterol, there may be some 
phospholipid extraction that occurs due to the nonspecific interactions of MBCD 
with membrane phospholipids, resulting in enhanced cholesterol loading under 
the reload condition.10, 22, 23 Despite this possible nonspecific interaction of MBCD 
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and phospholipids, the results from MBCD enabled cholesterol manipulation are 
in good agreement with a previous study examining cholesterol effects using 
metabolic depletion of membrane cholesterol. 23 In this work, the reload condition 
is treated simply as a high cholesterol level condition. Several previous studies 
have examined the localization of various structures, including receptors and 
caveolae, within the membrane of various cell types by using MBCD-enabled 
cholesterol manipulation, including reloading with MBCD-cholesterol complexes. 
Given the dynamic nature of the plasma membrane, these studies have seen 
disruptions that indicate the membrane is not necessarily fully restored to its 
original condition after MBCD–cholesterol reloading.24-27   
 
5.3.2 K+-stimulated Release vs. Ba2+-stimulated Release  
Different granule pools of the chromaffin cells can be targeted depending on the 
secretagouge used. As shown in previous studies, high K+ triggers mainly the 
release of RRP granules whereas Ba2+ recruits the release of older granules.13 
Figure 5.1 shows sample amperometric traces from K+ double stimulation (Fig. 
5.1A) and Ba2+ stimulation (Fig. 5.1B) experiments. When cells were exposed to 
high K+ concentration, the granules belonging to the RRP show an immediate 
response and release their granular content with a burst behavior. However, 
release of granules upon Ba2+ stimulation show a delayed response since these 
older granules need to be trafficked to the plasma membrane, supporting 
previous findings that RRP granules and RP granules have different levels of 
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competency for release of their contents.15, 16 In addition, Ba2+ stimulation results 
in a sustained release over a longer period of time. From a collection of K+-
stimulated traces (n=27 cells) and Ba2+- stimulated traces (n=18 cells), an 
average of 54±7 granules/ cell release their vesicular content following K+ 
stimulation compared with 352±32 granules/cell when cells were triggered by the 
Ba2+ secretagogue (p<0.0001). Keeping in mind that the carbon-fiber 
microelectrode samples from only ~10% of the cell surface area, it is clear that 
the K+- stimulation incites release of more than just the RRP, likely drawing at 
least a portion of the SRP as well. 
5.3.3 Effect of Membrane Cholesterol on Release of Young Granular Pools 
The RRP/SRP granules reside near the cellular membrane, and some are 
primed to immediately release their content upon depolarization of the membrane 
with K+ (60 mM). Amperometry results, collected from 18, 17, and 20 cells for 
control, MBCD and reload conditions, respectively (Figure 5.2), show that the 
quantal release of catecholamine from these granules with varied membrane 
cholesterol content did not change (Q=671.8±96.5 fC, 720.8±99.1 fC, 493.4±70.4 
fC for MBCD, control and reload, respectively, p>0.05). 
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Figure 5.1 Representative amperometric traces of release from different 
chromaffin cell granular pools: (A) preferential release of RRP vesicles twice 
upon repeated stimulation with 60 mM K+ and (B) release of RP granules with 
Ba2+ stimulation. The bar underneath the amperometric traces indicates the time 
and the duration of the stimulation. 
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This result indicates that changing the membrane cholesterol levels does not 
have any influence on the storage of chemical messenger molecules within 
RRP/SRP granules. Moreover, there was not a significant change in the kinetics 
of release events observed with altered membrane cholesterol levels (Figure 
5.2C, p>0.05). This implies that membrane cholesterol does not affect the 
efficacy of the dilation of the fusion pore to the fully fused state or expansion of 
the granular matrix to release catecholamine content from RRP/SRP granules. 
This is somewhat surprising since the SNARE proteins, known to play an 
important role in cell–vesicle fusion, are influenced by membrane cholesterol 
levels.2-4 Perhaps, in the already docked RRP vesicles, the SNARE protein 
function has already been performed, making membrane cholesterol levels less 
influential than in granules that must be trafficked and docked at the membrane 
upon stimulation. Another possible interpretation is based on the fact that the 
chromaffin cell’s plasma membrane is known to have higher cholesterol content 
than the intracellular membrane and that intracellular cholesterol content is 
regulated based on the overall cholesterol level in the plasma membrane.10, 22  
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Figure 5 2 Analysis of the amperometric results from K+-stimulated release at 
altered cellular cholesterol levels indicating: (A) there is not a significant change in 
quantal catecholamine storage/release, (B) low cholesterol levels destabilize the 
intermediate fusion pore state and fewer foot events occur when cells are treated 
with MBCD, and (C) the time required for full fusion to occur does not change, and d 
both high and low cholesterol levels facilitate the overall release process. 
(**represents p<0.001) 
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The half time for transport of cholesterol from the endoplasmic reticulum to the 
plasma membrane upon cholesterol depletion is between 10 min and 1 h.10, 22, 28 
Hence, it is possible that, even under conditions of membrane cholesterol 
depletion by MBCD, the cholesterol rich domains still form via membrane 
rearrangement and cholesterol supply from different parts of the cell to meet the 
critical cholesterol concentration requirements for SNARE function. Given the 
dynamic nature of the plasma membrane, to differentiate between these two 
possible hypotheses, one would need either dynamic real-time single cell 
imaging of the lipid rafts or knockout mice for specific SNARE components 
involved in the docking and priming steps. While informative, these experiments 
are beyond the scope of the current work reported here. Among K+-stimulated 
cells, there was, however, a significant decrease in foot events observed when 
membrane cholesterol concentration was depleted, and this effect was remedied 
upon replenishment of the membrane cholesterol (Foot%=6.1±1.1, 11.2±1.0, 
9.3± 1.6 for MBCD, control, and reload, respectively). Although it is difficult to 
predict the exact effect of cholesterol on fusion pore properties, the stalk model 
for membrane fusion suggests that cholesterol supports the negative curvature of 
the fusion pore intermediate and stabilizes it. Thus, lower fusion pore occurrence 
at lower cholesterol level agrees with the stalk model of the fusion pore and 
shows that more cholesterol is needed to support the negative curvature of the 
fusion pore and/or the rigidity of the cell/granule membrane fusion site. 
Interestingly, cumulative frequency results show that both high and low 
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cholesterol levels facilitate the trafficking and release of RRP/SRP granules; the 
reasons for this will be addressed later (Figure 5.2D). 
5.3.4 Effect of Membrane Cholesterol on Subsequent Release Event 
Chromaffin cells can recycle their granular content through the process of 
endocytosis within 30 s after exocytosis.21, 29 To explore the role of membrane 
cholesterol in granule recycling and subsequent release events, chromaffin cells 
were stimulated twice, at 3 and 33 s, with a 3-s bolus of 60 mM K+ (n=27, 30, and 
33 cells for control, MBCD, and reload conditions, respectively). Then, the ratio of 
the spike parameters from each stimulation were evaluated for significant 
differences from unity, indicating incomplete recovery after the initial stimulation. 
Results (Fig. 5.3) of this analysis show that chromaffin cells with normal cellular 
cholesterol levels (control) release less catecholamine in the second stimulation 
compared with the first stimulation, (Q1/ Q2)control=1.491±0.136. This difference 
between the first and second stimulation becomes less prominent in the case 
with depleted membrane cholesterol (Q1/Q2)MBCD=1.114± 0.126, which shows 
more complete quantal recovery of the cholesterol-depleted cells between 
subsequent release events (p<0.05). The high cholesterol condition shows 
indistinguishable behavior from the control condition, with 
(Q1/Q2)Reload=1.338±0.088, further supporting better quantal recovery at low 
cholesterol levels. Although, regardless of cholesterol level, the parameter 
indicating total time of the release event ((T1/2)1/(T1/2)2; Figure 5.3B) did not 
change significantly from unity, while the time required for dilation of the fusion 
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pore did change between the first and second release events in the case of low 
cholesterol, with (Trise)1/ (Trise)2=1.402±0.1568 (p<0.05 compared with unity).  
Hence, there is more rapid transition from fusion pore to full dilation when cells 
are stimulated a second time in the case of depleted cellular cholesterol levels. 
The Foot% ratios were significantly larger than unity (p<0.05) for all the 
conditions ((Foot%)1/(Foot%)2=1.277±0.108, 1.292±0.113, 1.317±0.151 for 
MBCD, control, and reload conditions, respectively), suggesting that there is a 
change in the stability of the fusion pore from stimulation to stimulation. However, 
these ratios were not distinguishable from one another, arguing that cholesterol 
does not play a role in this change. This may be explained by the reconstruction 
of the cell membrane and granules during the exocytosis/endocytosis cycle, 
yielding fewer or smaller cholesterol-enriched microdomains for the second 
stimulation, and thus, less robust fusion pores. 
5.3.5 Effect of Membrane Cholesterol on Reserve Pool Granules 
The chromaffin cell reserve pool constitutes the older population of granules, and 
these vesicles do not get activated upon K+ stimulation but release their vesicular 
content when stimulated by Ba+2.18-20 Although the mechanism of Ba2+ activation 
is still under debate, it is thought that Ba2+ can activate chromaffin cell secretion 
through T-type Ca2+ channels, which was shown to have similar permeability for 
both Ca2+ and Ba2+.13  
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Figure 5.3 Ratiometric analysis of the double K+ stimulation experiments.(A) 
In control and reload conditions, cells released less catecholamine in the 
second stimulation compared with the first one (significant difference from 
unity). Full quantal recovery was observed for cells treated with MBCD. (B) 
Total duration of the release event did not change between stimulations. (C) 
(Trise)1/(Trise)2 is significantly (p<0.05) different than unity for MBCD, indicating 
that transition from the fusion pore to full dilation process changes between 
the first and second release. (D) (Foot%)1/ (Foot%)2 showed significant 
changes in foot occurrence between the first and second release for all 
conditions 
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To avoid Ca2+ interference, Ca2+-free solutions were used during Ba2+ stimulation 
experiments. Reserve pool granules were activated to release their granular 
content via delivery of a 3-s bolus of 5 mM Ba2+ to cells with altered membrane 
cholesterol levels (n=18, 21, and 20 cells for control, MBCD, and reload 
conditions, respectively).  
Figure 5.4 shows representative amperometric traces of catecholamine release 
from control (Figures. 5.4A or 5.1B), MBCD (Figure 5.4B), and reload (Figure 
5.4C) conditions. Clearly, there is a drastic reduction in the number of granules 
successfully releasing their content when the membrane cholesterol level is 
manipulated in either direction (no. of granules detected=352±32, 188±21, and 
183±24 per cell for control, MBCD, and reload conditions, respectively). 
Assuming that this change is not a result of MBCD exposure itself, this result 
reveals that appropriate cholesterol levels are crucial for the efficient recruitment 
of the older granules to release. Moreover, although cholesterol does not 
influence the quantity of catecholamine released from the RP granules (based on 
Q analysis), depleted cholesterol levels slow down the kinetics of exocytosis 
(Figure 5.5). 
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Figure 5.4 Representative amperometric traces of preferential release of RP granule 
release upon Ba2+ stimulation (A) control, (B) MBCD-treated, and (C) reloaded chromaffin 
cells 
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Unlike RRP granules, RP granules form a more stable fusion pore, with a higher 
occurrence of foot events at low membrane cholesterol levels (Foot%=15.2±1.59, 
10.0±0.83, and 11.6±1.08 for MBCD, control, and reload conditions, 
respectively). Together, these data imply either that RP vesicles release their 
content from different sites on the membrane than RRP/SRP granules or that the 
structure of the fusion pore is different for RP granules, such that cholesterol 
destabilizes this intermediate state. Unfortunately, with current techniques, 
determination of the fusion pore structure with RP granules is not possible. 
Figures 5.4C and 5.5D demonstrate that, although higher cholesterol levels 
decrease the number of granules recruited for release, most of the granules 
release their content earlier than control and cholesterol-depleted cells, revealing 
that high cholesterol levels facilitate the trafficking and release of this granule 
pool; this relationship is the subject of future work. 
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Figure 5. 5 Analysis of the amperometric data from Ba2+-stimulated granule release: (A) shows 
no significant change in the quantal storage/release of RP granule content at altered 
cholesterol levels, (B) Foot% analysis shows that RP granules form more stable fusion pore 
intermediates at depleted cholesterol levels, and (C) higher rise time indicates slower transition 
from fusion pore to full dilation in RP granules of MBCD-treated cells, and d % cumulative 
frequency analysis of the all events shows more efficient trafficking at high cholesterol levels. 
(*denotes p<0.005 and **denotes p<0.001) 
A C
B D
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5.4 Comparison of Chromaffin Cells and Platelets  
This work demonstrated that kinetics of chromaffin cell exocytosis is largely 
unchanged with altered cholesterol levels, unlike the recently measured behavior 
of exocytosing platelets.30 This difference is likely due to the fact that, unlike 
platelets, chromaffin cells have a nucleus and a significant synthesis capacity 
that enables them to tightly regulate various cell functions. Accordingly, when 
plasma membrane cholesterol is depleted, chromaffin cells rescue the secretion 
kinetics and quantity of the release whereas the largely static, anuclear platelet 
cannot accomplish this task. Moreover, chromaffin cells store their granular 
content in a proteinaceous matrix, and expansion of the matrix following initial 
membrane fusion is considered one of the main driving forces of full fusion and 
release.10, 18, 29, 31, 32 However, platelet secretory granules do not contain this type 
of matrix, and accordingly, full fusion events are more dependent on the 
membrane properties.30  However, cholesterol alteration did result in similar 
fusion pore effects in platelets and chromaffin cell RRP granules, indicating 
similar fusion pore structures in these two distinct cell types.  
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